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ABSTRACT 
 
 
This study was carried out to investigate the possible effects of three traditional 
medicinal plants extracts in the correction of anemia. These plants were: seeds of Hibiscus. 
sabdariffa (Kerkade), fruits of Azanza. garckeana (Jakjak) and fruits of the common plant 
Grewia . tenax (Guddeim). Two types of anemia were chosen for the study: hemorrhagic anemia 
(by using hemorrhagic bled rats) and nutritional anemia (by using nutritionally iron- deficient 
rats). A constant dose of 2g/kg body weight of aqueous extract is used for the evaluation of the 
possible effects of these three plants on the two types of experiments on various hematological 
parameters of anemic rats. 
Estimation of iron content of the three plants revealed that G. tenax has had the highest 
value of iron content, and A. garckeana extract came second; while H. sabdariffa extract has had 
the least amount of iron content.   
The three aqueous extracts of the three plants caused significant-increases in the 
hemoglobin (Hb), Packed corpuscular volume (PCV) and Red blood cell count (RBC) of the 
hemorrhagic anemic rats, throughout the first and second weeks of experiments; in addition to 
that, extracts of G. tenax and H. sabdariffa continued to have the same favorable effect to the 
third and fourth weeks of the experiment. However, these extracts did not cause any noticeable 
effects on other hematological parameters (Mean corpuscular volume (MCV), Mean corpuscular 
hemoglobin (MCH) and Mean corpuscular hemoglobin concentration (MCHC).   
Studies carried out on iron-deficient anemic rats revealed that only G. tenax and H. 
sabdariffa extracts that had small and equal effects on the hemoglobin levels and red blood cell 
counts of the rats, but with no effect on other hematological parameters.  
The effects of A. garckeana extract and H. sabdariffa extract on iron absorption were 
studied by using rat everted gut sac technique. The obtained results were compared with that of a 
former study carried out on fruits of G. tenax.  
It was found that, H. sabdaiffa extract had better tendency in increasing iron absorption 
than did the A. garckeana extract when compared to the capability of G. tenax extract in 
increasing iron absorption performed in that former study.   
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 ﻣﻠﺨﺺ اﻟﺪراﺳﺔ
 
 و ﻗﺪ ﺷﻤﻠﺖ هﺬﻩ ﺗﺴﺘﻌﻤﻞ ﺗﻘﻠﻴﺪﻳﺎ آﻌﻼج ﻃﺒﻲ ﻟﻔﻘﺮ اﻟﺪم ﻓﻲ اﻟﺴﻮدان اﻟﺪراﺳﺔ ﻟﺘﻘﻴﻴﻢ ﺗﺄﺛﻴﺮﻣﺴﺘﺨﻠﺼﺎت ﺛﻼث ﻧﺒﺎﺗﺎت أﺟﺮﻳﺖ هﺬﻩ
 ﺗﻢ ﺟﻤﻊ هﺬﻩ اﻟﻨﺒﺎﺗﺎت و ﺣﻠﻠﺖ .ﺎﻟﻘﻀﻴﻢﺑﺑﺬور ﻧﺒﺎت اﻟﻜﺮآﺪي، ﺛﻤﺎر ﻧﺒﺎت اﻟﺠﻐﺠﻎ و ﺛﻤﺎر اﻟﻨﺒﺎت اﻟﻤﻌﺮوف : اﻟﻨﺒﺎﺗﺎت
ﺬﻩ اﻟﻤﺴﺘﺨﻠﺼﺎت اﻟﻨﺒﺎﺗﻴﺔ ﻗﺪ أﺛﺒﺘﺖ اﺣﺘﻮاء ﻧﺒﺎت اﻟﻘﻀﻴﻢ ﻋﻠﻰ أﻋﻠﻰ آﻤﻴﺎت ﻧﺴﺐ اﻟﺤﺪﻳﺪ ﻓﻲ هﻣﺤﺘﻮﻳﺎﺗﻬﺎ ﻣﺨﺘﺒﺮﻳﺎ ﺑﺘﺮآﻴﺰ ﻋﻠﻰ 
   .ﻧﺴﺒﺔ ﻣﻦ اﻟﺤﺪﻳﺪ، ﻳﻠﻴﻪ ﻧﺒﺎت اﻟﺠﻐﺠﻎ و أﻗﻞ ﻧﺴﺒﺔ وﺟﺪت ﻓﻲ ﻧﺒﺎت اﻟﻜﺮآﺪي
  :ﺗﻢ اﺧﺘﻴﺎر ﻧﻮﻋﻴﻦ ﻣﻦ اﻧﻮاع اﻷﻧﻴﻤﻴﺎ ﻻﺟﺮاء اﻟﺪراﺳﺔ، و هﻤﺎ
  .اﻷﻧﻴﻤﻴﺎ اﻟﻨﺰﻓﻴﺔ، و ذﻟﻚ ﻋﻦ ﻃﺮﻳﻖ اﺟﺮاء اﻟﻨﺰﻳﻒ ﻟﺠﺮذان اﻟﺘﺠﺎرب( 1) 
  . ﻨﻘﺺ اﻟﺤﺪﻳﺪ ﻓﻲ اﻟﻐﺬاءﻋﺮﺿﺖ ﻟﻧﻴﻤﻴﺎ ﻧﻘﺺ اﻟﺘﻐﺬﻳﺔ اﻟﺘﺠﺮﻳﺒﻲ، و ذﻟﻚ ﻋﻦ ﻃﺮﻳﻖ اﺳﺘﺨﺪام ﺟﺮذان أ( 2)
ﻟﺘﻘﻴﻴﻢ  (آﺠﻢ ﻣﻦ وزن اﻟﺤﻴﻮان/ ﺟﻢ2 )ﻓﻲ هﺬﻩ اﻟﺘﺠﺎرب و هﻲﻣﻦ اﻟﻤﺴﺘﺨﻠﺺ اﻟﻤﺎﺋﻲ ﻟﻬﺬﻩ اﻟﻨﺒﺎﺗﺎت ﺗﻢ اﺳﺘﺨﺪام ﺟﺮﻋﺔ ﻣﻮﺣﺪة 
 ﻤﺎﺋﻴﺔ ﻟﻠﻨﺒﺎﺗﺎت اﻟﻄﺒﻴﺔ ﻓﻲ ارﺗﻔﺎعاﻟﻤﺴﺘﺨﻠﺼﺎت اﻟﺗﺴﺒﺒﺖ هﺬﻩ . ﻋﻠﻰ ﻣﺨﺘﻠﻒ ﻣﻜﻮﻧﺎت دم اﻟﺠﺮذان اﻟﻤﺼﺎﺑﺔ ﺑﺎﻷﻧﻴﻤﻴﺎأﺛﺮهﺎ 
ﺎ وﻓﻲ ﻋﺪد آﺮﻳﺎت اﻟﺪم اﻟﺤﻤﺮاء و ﻗﺪ آﺎن ﻳ اﻟﺨﻼﺒﻮسﻟﻨﺴﺐ هﻴﻤﻮﻗﻠﻮﺑﻴﻦ اﻟﺪم، ﻓﻲ آ( دﻻﻟﺔ اﺣﺼﺎﺋﻴﺔ) أﺛﺒﺖ اﺣﺼﺎﺋﻴﺎ ﻣﻌﻨﻮي
 ﺑﺎﻻﺿﺎﻓﺔ اﻟﻰ ذﻟﻚ، أﻇﻬﺮ. ذﻟﻚ ﻓﻲ ﺣﺎﻟﺔ اﻷﻧﻴﻤﻴﺎ اﻟﻨﺰﻓﻴﺔ ﻓﻲ ﺧﻼل اﻷﺳﺒﻮﻋﻴﻦ اﻷول و اﻟﺜﺎﻧﻲ ﻣﻦ اﺟﺮاء اﻟﺘﺠﺎرب
  . اﻟﺜﺎﻟﺚ و اﻟﺮاﺑﻊ ﻣﻦ اﻟﺘﺠﺮﺑﺔآﺪي ﺗﺄﺛﻴﺮا اﻳﺠﺎﺑﻴﺎ اﻣﺘﺪ ﻟﻸﺳﺒﻮعﻣﺴﺘﺨﻠﺼﻲ ﻧﺒﺎﺗﻲ اﻟﻘﻀﻴﻢ و اﻟﻜﺮ
أﺛﺒﺘﺖ اﻟﺪراﺳﺎت اﻟﺘﻲ أﺟﺮﻳﺖ ﻋﻠﻰ ﺟﺮذان ﻧﻘﺺ اﻟﺤﺪﻳﺪ، أن ﻣﺴﺘﺨﻠﺼﻲ ﻧﺒﺎﺗﻲ اﻟﻘﻀﻴﻢ و اﻟﻜﺮآﺪي ﻗﺪ أﻇﻬﺮا ﺗﺄﺛﻴﺮا ﺿﻌﻴﻔﺎ و 
ﻟﻜﻦ ﻟﻢ ﻳﻜﻦ ﻟﺪﻳﻬﺎ ﺗﺄﺛﻴﺮ . ﻟﺤﻤﺮاء ﻓﻲ دم ﺗﻠﻚ اﻟﺠﺮذانﻟﻜﻦ ﻣﺘﺴﺎوﻳﺎ ﻋﻠﻰ ﻣﺴﺘﻮى اﻟﻬﻴﻤﻮﻗﻠﻮﺑﻴﻦ و آﺬﻟﻚ ﻋﻠﻰ ﻋﺪد آﺮﻳﺎت اﻟﺪم ا
  .واﺿﺢ ﻋﻠﻰ ﻣﻜﻮﻧﺎت اﻟﺪم اﻷﺧﺮى
ﺗﻤﺖ دراﺳﺔ ﺗﺄﺛﻴﺮ ﻣﺴﺘﺨﻠﺼﻲ ﻧﺒﺎﺗﺎت اﻟﺠﻐﺠﻎ و اﻟﻜﺮآﺪي ﻋﻠﻰ اﻣﺘﺼﺎص اﻟﺤﺪﻳﺪ و ذﻟﻚ ﻋﻦ ﻃﺮﻳﻖ اﺳﺘﺨﺪام ﺗﻘﻨﻴﺔ أﻣﻌﺎء 
  . ﻣﺴﺘﺨﻠﺺ ﻧﺒﺎت اﻟﻘﻀﻴﻢﺖ ﻣﻊوﺗﻮاﻓﻘ ﻧﺘﺎﺋﺞ هﺬﻩ اﻟﺪراﺳﺔ ﺑﻤﺎ ﺳﺒﻘﻬﺎ ﻣﻦ دراﺳﺎتﻗﻮرﻧﺖ . اﻟﻤﻘﻠﻮﺑﺔواﻟﺠﺮذان اﻟﻤﻌﺰوﻟﺔ 
 أﻇﻬﺮت اﻟﻨﺘﺎﺋﺞ اﻟﺘﻲ وﺟﺪت ﺑﺎن ﻣﺴﺘﺨﻠﺺ ﺑﺬور اﻟﻜﺮآﺪي ﻟﻪ ﺧﺎﺻﻴﺔ ﻓﻲ زﻳﺎدة اﻣﺘﺼﺎص اﻟﺤﺪﻳﺪ أﻓﻀﻞ ﻣﻦ ﺗﻠﻚ اﻟﺘﻲ 
  . ﻳﺮﺗﻘﻲ ﻟﻤﻌﺪل ﻣﺎ أﻇﻬﺮﻩ ﻣﺴﺘﺨﻠﺺ ﻧﺒﺎت اﻟﻘﻀﻴﻢ ﻓﻲ اﻟﺪراﺳﺎت اﻟﺴﺎﺑﻘﺔوﺟﺪت ﻓﻲ ﻣﺴﺘﺨﻠﺺ ﻧﺒﺎت اﻟﺠﻐﺤﻎ و
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INTRODUCTION 
 
 
Anemia and iron deficiency constitute the most frequent nutritional problems 
worldwide. Some age groups are more vulnerable to suffer this deficiency, especially as a 
consequence of increased requirements and/or losses of the mineral. For these reason infants, 
preschoolers and pregnant and childbearing age women are more susceptible to iron 
deficiency (INACG, 1977 and WHO, 1993).  
Most programs up to date, focused on iron supplementation and /or fortification. 
However, food supplementation programs are relatively expensive, non compliance and result in 
complex interaction between supplements and endogenous food components. Thus, a sustainable 
solution to dietary iron deficiency is required to reduce significantly the prevalence of iron 
deficiency anemia especially in the third world communities.  
Worldwide, different plants were investigated for their role in the treatment and 
correction of different types of anemia, their iron content and their ability to enhance iron 
absorption in the body. So herbal medications can be considered as one of the solutions to 
dietary iron deficiency and can be the replacement for food supplementation programs especially 
in areas of illiterate populations where natives lack appropriate health care.  
Sudan with its vast areas is rich in wild plants that play an important role in the nutrition 
of different populations especially in rural areas. Not many of these plants are scientifically 
investigated for their role in treatment of anemia. However a popular indigenous fruit, Grewia 
tenax, locally known as "Guddeim" is the first plant to be studied.  
Grewia tenax is available in markets in wide areas in Sudan. It has been previously 
studied for its ability to treat anemia. It was stated that it increases blood hemoglobin level and 
increases iron absorption. On the other hand, there were other indigenous plants that were used 
by natives in folk medicine for the same role, especially in Kordofan States (Western Sudan). 
Those plants were not exposed to scientific studies to investigate this folkloric assumption. 
Examples for these plants are: seeds of Hibiscus sabdariffa and fruits of Azanza garckeana. 
These plants were studied for other activities and assumptions, however, no studies were found 
to evaluate their role in the treatment of anemia.  
Thus, the current study is directed for investigation of the efficiency of H. sabdariffa 
seeds and A. garckeana fruits in the treatment of anemia in comparison to the effects of G. tenax 
fruits in the previous studies.  
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Objectives of the study: 
• To investigate the efficiency of three medicinal plants which are used in folk medicine in 
the Sudan for the treatment of anemia. 
• To evaluate chemical composition of these plants. 
• To investigate the tendencies of those plants to increase iron absorption and/ or 
availability in the body. 
• To compare between the anti-anemic effects of the three plants.       
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
LITERATURE REVIEW 
 
1.1. Definition of anemia: 
Anemia is defined as a condition in which the number of red blood cells (RBC) or 
the amount of hemoglobin (Hb) which carries oxygen in them is low as stated by Allan 
(2008).   
Hemoglobin enables the red blood cells to carry oxygen to the lungs and deliver it to 
all parts of the body. When the number of red blood cells is reduced or the amount of 
hemoglobin in them is low, an inadequate supply of oxygen in the tissues produces the 
symptoms of anemia. (Allan, 2008)   
1.2. Anemia Overview: 
Blood is actually a liquid made up of several different cell types. One of the most 
important and most numerous cell types is the red blood cell. The purpose of the red blood 
cell is to carry and deliver oxygen to the body cells. Anemia describes the condition in which 
the number of red blood cells in the blood is low.  
Passmore (1986) stated that anemia is actually a sign of a disease process rather than 
a disease itself. It is usually classified as either chronic or acute. Chronic anemia happens 
over a long period of time. Acute anemia happens quickly. The life of the red blood cells is 
about 120 days. The bone marrow replaces them at a rate which enables their numbers to be 
maintained for optimum health. For the production of erythrocytes many nutrients are 
needed e.g. iron, copper, protein, vitamins C, B12 and E and folate.  
1.3. Anemia in animals: 
A deficiency of iron in the diet of animals causes anemia and failure to thrive. It is 
most likely to occur in newborn animals whose sole source of iron is the milk of the dam, 
milk being a poor source of iron. However, anemias in animals are classified as hemorrhagic 
or hemolytic anemia or anemia due to decreased production of erythrocytes. Hemorrhagic 
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anemia may be due to spontaneous rupture or traumatic injury to large blood vessels. The 
primary hemorrhagic diseases are less common e.g. abomasal ulcer, pyelonephritis, sweet 
clover poisoning, massive hook worms. 
Hemolytic anemia is caused by diseases like babesiosis, leptospirosis, weeds 
poisoning, copper poisoning …etc. Hemolytic anemia can be sufficiently severe to cause 
hemoglobinuria and may result in hemoglobinuric nephrosis and depression of renal 
function; while anemia due to nutritional deficiency is reversible. In clinical cases of anemia, 
there are signs of pallor mucus membranes, muscular weakness, depression and anorexia. 
(Blood et al, 1986) 
On the other hand, Blood et al. (1986) also stated that deposits of iron in the liver of 
the newborn are insufficient to maintain normal hemopoiesis for more than 2-3 weeks. More 
than half of the iron in the animal body is found as a constituent of hemoglobin. A relatively 
small amount is found in myoglobin and in certain enzymes which play a part in oxygen 
utilization. Iron-deficiency conditions are not common in farm animals except in the very 
young confined to a milk diet. However, continued blood loss by hemorrhage in any animal 
may bring about a sub clinical anemia and an associated iron deficiency.  
Cattle heavily infested with sucking lice may develop serious and even fetal anemia. 
The chronic form is characterized by a non-regenerative anemia with sub-normal levels of 
serum iron and treatment with iron is necessary for an optimal response. 
Horses heavily infested with blood- sucking strongylid worms develope often sub-
normal hemoglobin levels and respond to treatment with iron. 
On occasions veal calves, and possibly young lambs and kids, may also suffer from an iron-
deficiency. 
Confirmation of diagnosis will depend upon hemoglobin determinations and curative 
and preventive trials with administered iron.  
Treatment of anemia in animals includes blood transfusion and hematinic preparation. Iron 
administered by mouth or parenterally is in common use. Vitamin B 12 is widely used as a 
non-hematinic particularly in horses. In extreme cases of anemia, irreversible changes 
caused by anoxia of kidneys and heart muscle, may prevent complete recovery in spite of 
adequate treatment.  
1.4. Biologic importance of heme: 
Iron is a part of heme, which is the active site of electron transport in cytochromes 
and cytochrome oxidase. Heme is also the site of oxygen uptake by myoglobin and 
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hemoglobin, thereby providing the means of transporting oxygen to tissues and within 
muscle cells. Hemoglobin in the root nodules of legumes protects nitrogen-fixing enzymes 
of symbiotic bacteria from oxidative inactivation; the ammonia formed is important in the 
synthesis of amino acids and proteins. The amino acids and proteins of legumes are 
transferred through the food chain to herbivores and thence to humans. Heme is also the 
active site of peroxidases that protect cells from oxidative injury by reducing peroxides to 
water. (Maurice et al, 1999) 
 
 
Figure 1. Structure of Heme 
 
1.4.1. Hemoglobin: 
The oxygen-carrying molecule in red blood cells is hemoglobin. Hemoglobin is a 
large, complex molecule. It contains an atom of iron reduced in the ferrus form at its center. 
Iron attaches itself easily to oxygen atoms. It is the iron in hemoglobin that actually carries 
oxygen to cells. 
Hemoglobin has the following properties. It is the major protein containing substance 
of the red blood cells. Hemoglobin, along with its cofactor heme, is synthesized in immature 
red blood cells. Hemoglobin functions as oxygen carrier. It has a molecular weight of 64.500 
and is composed of four subunits. Each subunit contains a heme group, which can bind one 
molecule of O2.   
Another feature of Hb is that it responds to the pH of the blood stream. Acidic pH 
increases a decrease in the affinity of Hb for O2 (The Bohr Effect). This effect is useful in 
promoting the release of O2 in active tissues, where there is increased production of CO2. 
The CO2 enters the red blood cells, where it is converted to carbonic acid by the action of 
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carbonic anhydrase. The acid dissociates in the cell, inducing release of O2 to the tissues. 
The Bohr Effect is dependant on the presence of both forms of globin. (Maurice et al,1999) 
 
1.4.2. Myoglobin: 
 Maurice, et al (1999) stated that myoglobin is a monomeric protein with a molecular 
weight of 16.900. It is a minor protein of muscle and is used for short- term storage of 
oxygen. Myoglobin binds oxygen more tightly than Hb does. The rate of oxygen release 
increases when the environment contains very low levels of oxygen.  
  
1.5. Iron: 
Iron is the most abundant trace element in the human body (3-4 g). The bulk of iron 
circulates in the erythrocytes in the form of hemoglobin. Much smaller amounts are carried 
in the blood bound to a specific plasma protein, transferrin. Each molecule of transferrin can 
accommodate two molecules of iron. The ability of transferrin to bind iron is called the total 
iron-binding capacity (TIBC). Transferrin can be estimated from TIBC by the formula:  
                                            
                                Transferrin (mg/dl) = TIBC/ 1.45 (Margaret et al, 1995) 
 
Ferritin is a water-soluble complex of iron and protein. It is more easily mobilized 
than hemosedrin for Hb formation. It is present in small amounts in plasma. 
Hemosedrin is an insoluble iron-protein complex found in macrophages in the bone marrow, 
liver and spleen. Un-like ferritin, it is visible by light microscopy in tissue sections and bone 
marrow films after staining by Perls reaction. (Parveen et al. 1999) 
In humans, the total quantity of body iron varies with weight, hemoglobin 
concentration, sex and the size of the storage compartment. Of these, the largest is the iron in 
hemoglobin. 
  To some extent, the body's needs for iron can be controlled at the point of absorption 
and normal iron balance is maintained largely by regulation of iron absorption. Ingested 
inorganic iron is solubilized and ionized by acid gastric juice, reduced to the ferrous form 
(Fe II), and chelated. Iron absorption is promoted by substances that form low molecular 
weight iron chelates, such as ascorbic acid, sugars and amino acids. The mucin of normal 
gastric juice chelates and stabilizes iron, thereby reducing its precipitation at the alkaline pH 
of the small intestine. 
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Absorption may occur at any level of the small intestine but it is most efficient in the 
duodenum. The divalent or Ferrus form of iron is more readily soluble than the trivalent or 
Fe (III) because of the low solubility of ferric hydroxides and phosphates at the alkaline pH 
of intestinal fluid. Thus, Fe (II) traverses more readily the mucous layer to reach the brush 
border of intestinal epithelial cells. (Maurice et al, 1999) 
Heme- iron forms the main part of dietary iron and derived from hemoglobin and 
myoglobin in red or organs meats. Non-heme iron is mainly derived from cereals which are 
commonly fortified with iron. Heme-iron is better absorbed than non-heme iron whose 
availability is more affected by other dietary constituents. 
To be absorbed, iron contained in heme-proteins must be successfully liberated, first 
by digestion of the protein, with liberation of heme. Heme is absorbed as such by the 
mucosal epithelium of the small bowel. Within the cytosol, iron is liberated from 
protoporphyrin by the microsomal enzyme heme oxygenase which breaks the porphyrin ring 
yielding Fe (III), biliverdin and CO. Fe (III) is then bound by paraferritin and transported to 
the serosal side of the cell. Biliverdin is converted to bilirubin, which is transported in 
plasma to the liver for excretion. The carbon monoxide released by heme catabolism is 
transported to the lungs for excretion in exhaled air. 
Plotting the logarithm of iron dosage against the logarithm of iron absorbed yields a 
straight line. For each two- fold increment in iron dosage, a 1.6 fold increment in absorption 
can be anticipated. (Maurice et al, 1999) 
 
1.5.1. Factors influencing iron absorption: 
- Heme-iron is absorbed better than non-heme iron. 
- Ferrous iron is better absorbed than ferric iron. 
- Gastric acidity helps to keep iron in the ferrous state and soluble in the upper gut. 
- Formation of insoluble complexes with phytate or phosphate decreases iron 
absorption. 
- Iron absorption is increased with low iron stores and increased erythropoeitic activity 
e.g. bleeding, hemolysis and high altitude. 
- There is a decreased absorption in iron overload, except in hereditary 
hemochromatosis, where it is increased. (Parveen et al, 1999) 
- In plant foods, phytates- which are salts of inositol hexaphosphates- chelates iron 
thus rendering it unavailable for absorption by the body. (Harland et al,l 1980) 
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1.5.2. Iron Transport: 
In blood or other body fluids, iron is transported by a protein called transferrin. 
Transferrin binds iron that either is released from intestinal epithelium into the blood or 
lymph or is secreted from macrophages following degradation of hemoglobin. It distributes 
and transfers iron throughout the body to wherever it is needed, mostly to erythrocyte 
precursors in the bone marrow for new hemoglobin synthesis. Transferrin is the normal 
plasma protein that transports iron between various iron compartments.  
 The normal concentration of transferrin in plasma is about to 2.2 to 3.5 g/l. Since iron 
is the natural ligand of transferrin, the plasma concentration of transferrin may be measured 
by the amount of iron that it will bound (TIBC). Normal TIBC is about 45 to 80 Mmol (250-
450 Mg/dl). The amount of iron actually bound to trasferrin is measured as the serum iron 
concentration or SI. 
 When transferrin is 100 %, iron absorbed by the intestinal mucosa can not be bound 
by transferrin , most of this excess iron is deposited in hepatocytes. Only about 3 mg of iron 
is transferrin bound at any time. Yet turnover is very rapid, as 25-30 mg of iron is 
transported daily from sites of absorption or release to cells where iron is needed. Normally, 
70-90 % of this iron is taken up by the erythropoietic cells of bone marrow for hemoglobin 
synthesis. Smaller quantities are delivered to other cells for formation of myoglobin, 
cytochromes, perioxidases or other functional iron proteins. (Maurice et a,1999)  
 
1.5.3. Iron re-utilization:  
On the other hand, Maurice, et al (1999) also reported that the active manner in which 
the body conserves and reutilizes iron is an important characteristic of iron metabolism. More 
than 90 % of hemoglobin iron is repeatedly recycled by phagocytosis of old erythrocytes, which 
occurs chiefly in macrophages of the liver and spleen. Phagocytized red cells are digested at a 
rate sufficient to release approximately 20 % of the hemoglobin iron within a few hours, and the 
remainders are more slowly. The iron released by the action of the monocyte-macrophage 
system is bound to transferrin and is ultimately redistributed. About 40 % of the hemoglobin iron 
of non-viable erythrocytes reappears in circulating red cells within 12 days. The rate of 
reutilization varies considerably. The remainder of iron derived from hemoglobin catabolism, 
enters the storage pool as ferritin or hemosedrin and normally turns over very slowly: 
approximately 40 % remains in storage after 140 days. When the rate of erythropoiesis increases, 
however, storage iron may be released more rapidly from the storage pools to plasma transferrin. 
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Conversely, in the presence of chronic disease such as infection, rheumatoid arthritis or 
malignancy, the storage iron derived from hemoglobin catabolism is reused much more slowly.   
                  
1.5.4. Iron stores: 
Maurice, et al (1999) also stated that iron is stored in reticuloendothelial cells, 
hepatocytes and skeletal muscle cells (500-1500 mg). About 2/3 of this is stored as ferritin and 
1/3 as hemosedrin in normal individuals. Small amounts of iron are also found in plasma (about 
4 mg bound to transferrin) with some in myoglobin and enzymes.  
 
1.5.5. Iron Overload: 
Harland and Harland (1980) reported that, an excessive body burden of iron can be 
produced by greater than normal absorption from the alimentary canal, by parenteral injection or 
by combination of both. Excess iron is deposited largely as hemosiderin in reticuloendothelial 
cells or in the parenchymal cells of certain tissues. The site of deposition depends in part on the 
portal of entry. Excess iron derived from intestinal absorption is carried to tissues, bound by 
plasma transferrin and transferred to parenchymal and  reticuloendothelial cells and developing 
erythroblasts. In iron overload, serum iron concentrations and transferrin saturation are usually 
increased and the TIBC may be depressed.  
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1.6. Types of Anemia: 
More than four hundred different kinds of anemia have been identified. Many of them 
are rare. Some are mild medical problems, while others are moderate or serious. Some are so 
serious that they may cause death. Isselbacher (1994) summarized the descriptive types and 
causes of anemia in the following table: 
1.6.1. Summary of descriptive types and causes of anemia: [Table 1] 
 
Type  Lab values  Causes  
Macrocytic, 
normochromic  
MCV: > 
100fl MCHC: 
34  
Vitamin B12 deficiency, folate deficiency, vitamin 
C deficiency, chemotherapy (megaloblastic 
marrow); aplastic anemia, hypothyroidism 
(normoblastic marrow)  
Microcytic, 
hypochromic  
MCV: < 80 
MCHC: < 30  
Iron deficiency, thalassemia, sideroblastic 
anemia, chronic lead poisoning, anemia of 
chronic illness  
Normocytic, 
normochromic  
MCV: 80–
99fl MCHC: 
34 + / -2  
Iron deficiency (early), chronic disease  
MCV: mean corpuscular volume 
MCHC: mean corpuscular hemoglobin concentration 
fl: femtoliter (one quadrillionth of a liter)   
 
1.7. Causes of anemia: 
Uthman, (1998) reported that anemia is caused primarily by one of three conditions. The 
first is bleeding. Bleeding results in the loss of red blood cells from the body. The second 
condition is a decreased rate of red blood cell production. Red blood cells are not produced 
as fast as they die off. The third condition is an increased rate of red blood cell destruction. 
Red blood cells die off faster than they can be replaced by the body. Of these factors, 
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bleeding is the most common cause of anemia. Bleeding can be a chronic or acute problem. 
Some common causes of chronic bleeding include: 
• Cancer  
• Gastrointestinal (digestive system) tumors  
• Other diseases and disorders of the digestive system  
• Heavy menstrual flow  
• Hemorrhoids  
• Nosebleeds  
• Stomach ulcers  
• Long-term alcohol abuse  
On the other aspect, acute blood loss is usually the result of: 
• Childbirth  
• Injury  
• A ruptured blood vessel  
• Surgery   
1.8. Iron deficiency anemia: 
Anemia in the developing world is most commonly caused by an iron deficiency, 
which affects up to 50 percent of the population in some countries. Iron deficiency not only 
impairs the production of red cells in the blood, but also affects general cell growth and 
proliferation in tissues like the nervous system and the gastrointestinal tract. Red cells in a 
patient with iron-deficiency anemia are both microcytic and hypochromic. (Isselbacher, 
1994) 
Margaret et al. (1995) stated that Iron deficiency anemia develops when there is 
inadequate iron for hemoglobin synthesis. A normal level of Hb is maintained, for as long as 
possible, after the iron stores are depleted; latent iron deficiency is said to be present during 
this period. 
1.8.1. Causes of iron deficiency anemia: 
Parveen et al. (1999) has reported the causes of anemia in the following:  
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- Blood loss. 
- Increased demands such as growth and pregnancy. 
- Decreased absorption e.g. post gastrectomy. 
- Poor intake. 
Most iron deficiency is due to blood loss, usually from the uterus or gastrointestinal tract. 
Premenopausal women are always in a state of precarious iron balance owing to 
menstruation. 
 The most common cause of iron deficiency worldwide is blood loss from the 
gastrointestinal tract resulting from hookworm infestations. The poor quality of the diet, 
predominantly containing vegetables, also contributes to the high prevalence of iron 
deficiency in developing countries.  
Whereas Margaret et al (1995) stated that, in iron deficiency anemia, blood indices 
will be changed as follows: 
- Erythrocyte indices such as MCV, MCH and MCHC are low. 
- A decrease in the serum ferritin level is the first biochemical change occurring during the 
development of iron deficiency. It reflects depletion of iron stores. 
- In the intermediate stage of iron deficiency, serum ferritin continues to be low, and in 
addition, serum iron is low. 
- Transferrin increases thus increasing TIBC. 
 In summary, the sequence of total events in iron deficiency is: 
• Depletion of iron stores; serum ferritin decreases. 
• TIBC and free erythrocyte protoporphrin increases, iron saturation decreases. 
• Serum iron decreases; iron saturation decreases further. 
• Hb and PCV levels decrease (i.e anemia) 
• Erythrocyte indices (MCV, MCH and MCHC) decrease.  
 
1.9. Hemorrhagic anemia: 
This type of anemia is caused by excessive blood loss.  
1.9.1. Clinical findings:  
Evidence of hemorrhage, indirect-gastrointestinal, depends on the amount of blood 
lost, period of time during bleeding, and site of hemorrhage. Hemorrhage from multiple sites 
suggests clotting abnormalities. 
1.9.2. Laboratory findings:  
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* Initially the PCV will be normal because all components are lost in similar proportions. 
Animal may be in hypovolemic shock.  
* Splenic contraction delivers high-PCV blood (80%) to the circulation, temporarily 
increasing the PCV.  
* Starting 2-3 hours after onset and lasting for 2-3 days, the blood volume is restored by the 
addition of interstitial fluid. This causes dilution of the erythrocyte mass and the signs of 
anemia (reduced PCV, RBC, and Hb) become evident. Plasma proteins are also reduced.  
* Platelet numbers usually increase during the first few hours. Persistent thrombocytosis may 
suggest continued bleeding.  
* Neutrophilic leukocytosis commonly occurs by approximately 3 hours post-hemorrhage.  
* Signs of increased erythrocyte production (polychromasia, reticulocytosis) become evident 
by 48-72 hours and reach a maximum approximately 7 days after the onset of hemorrhage. 
Erythroid hyperplasia is evident in the bone marrow and precedes the changes in the 
peripheral blood.  
* Plasma protein concentration begins to increase in 2-3 days and returns to normal before 
the PCV, RBC, and Hb.  
* The hemogram returns to normal in 1-2 weeks in the dog.  
* Thrombocytopenia and subsequent hemorrhage may occur with primary bone marrow 
failure; the anemia in these cases is non-regenerative.  
1.9.3. Causes:  
Trauma, Surgery, GI ulcers, Hemostasis defects, Sweet clover, Warfarin, Bracken 
fern and Factor X deficiency in pups  
1.9.4 Characteristics of chronic blood loss:  
1.9.4.1 Clinical findings:  
1- Anemia develops slowly and hypovolemia does not occur.  
28 
 
2- PCV can reach low values before clinical signs of anemia become obvious because 
slow onset allows for physiologic adaptation.  
1.9.4.2 Laboratory findings:  
1. Regenerative response, but less intense than acute blood loss.  
2. Hypoproteinemia is usually not noted.  
3. Persistent thrombocytosis may be evident.  
4. Body stores of iron may become depleted and an iron-lack anemia develops.  
1.9.4.3. Causes:  
*Parasitism  
* Ancylostomiasis  
* Strongylosis-equines  
* Hemonchosis-ruminants  
* Coccidiosis  
* Fleas, ticks, lice  
* GI ulcers, tumors  
* Hematuria  
* Vascular neoplasms  
* Hemophilia  
* Thrombocytopenia  
* Vitamin K deficiency  
* Differential features between anemias caused by external and internal hemorrhage  
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* External blood loss prevents reutilization of certain components (iron, plasma, and 
protein). These may be reabsorbed with internal hemorrhage.  
* In internal hemorrhage, some erythrocytes are reabsorbed into lymphatics, particularly 
when hemorrhage is into body cavities, and the remainders are lysed or phagocytized, and 
iron and plasma proteins are reutilized. Therefore, the anemia may not be severe and 
recovery may be faster. (Murray et al, 2000). 
1.10. Treatment of anemia with drugs: 
Experiments carried out by Nenortiene et al, (2002) on new born piglets given anti-
anemic powder Ferosol-2 were conducted. Calcium, manganese and ascorbic acid were 
added to Ferosol-2. Manganese and ascorbic acid stimulated erythropoiesis and being strong 
reductants stabilize iron on storage and in gastrointestinal tract. Iron in Ferosol-2 was found 
to be well assimilated in gastrointestinal tract of piglets, easily gets into blood and joins 
albumin of plasma. Experimental data showed increased resorption of iron in Ferosol-2 
composition due to ascorbic acid. Ferosol-2 leads to significantly higher amount of 
hemoglobin and red blood cells in piglets.  
Another study conducted by Idoate et al, (2003) on the protective effect of 3 different 
anti-anemic preparations was carried out to compare the gastrodoudenal toxicity caused by 
the three types in normal and anemic rats administered repeated therapeutic doses. The 
preparations were ovoalbumin (TM/FMOA), iron protein succinylate and ferrous sulphate. 
The effectiveness of the preparations in resolving the anemia was similar in the three groups 
but TM/FMOA exerts a protective effect against the toxicity normally observed of the iron 
in other formulations in normal and anemic rats, which was attributed to the fact that 
administration of iron bound to a protein core allows for gradual release of iron.  
On the other hand, the response between food supplemented with iron in powdered 
and iron in syrup both used for the treatment of iron-deficiency anemia was evaluated in two 
groups of children by Ahmed et al (2003). The patients were randomized to receive either 
iron in syrup form, group (A) or equivalent doses of iron powder sprinkled over food, (group 
B). Hemoglobin rise in group B was more than in group A, but was statistically non-
significant (P<0.05). There was small but significant (P<0.05) rise in serum ferritin in both 
groups. There was no significant difference between the two forms of iron administration. 
The conclusion was that, the powder form of iron is a cost effective and better tolerated 
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method of iron administration in children and can be considered as an alternate option for 
the treatment of iron-deficiency anemia in children.  
In another study carried out on twenty women with iron-deficiency anemia. Tot’ 
tema drug was prescribed twice daily. Receiving dates confirmed excellent G.I. absorption, 
which guarantee Tot’tema efficacy. (Milchev et al, 2004) 
Ghinea (2004) has reported that, Ferro-Folgamma as one of the most indicated 
medicines in iron-deficiency. Due to its components this medicine has many indications: 
insufficient alimentary intake concerning iron, folic acid, B 12 vitamin, vegetarian 
alimentation, increased needs during growth period, iron-deficiency anemia secondary to 
chronic hemorrhages, malnutrition, anemias associated with chronic alcohol intake, 
preventive treatment of iron-deficiency anemia and megaloblastic anemia during pregnancy 
and lactation.   
 Bozhinova et al, (2004) recommended the utilization of Ferro-Flogamma for 
treatment and prophylaxis of iron-deficiency anemia in pregnant women, because of its good 
gastric acceptance, a few side undesired reactions and supplement of folic acid and vit. B 12 
increases the iron resorbtion.  
Another study carried out by Vermeer et al, (2002) on the efficacy of two iron 
products in preventing iron-deficiency. A total of 102 newborn piglets from ten litters were 
treated intramuscularly with 200 mg iron as iron dextran per ml, or 200 mg iron as 
gleptoferron per ml. Both products could be found between the two formulations. It could be 
concluded that iron-dextran and gleptoferron can be used with similar effect for anemia 
prevention in piglets.  
 
1.10.1. Availability of iron in plants: 
 Harland and Harland (1980) stated that, iron absorption is an issue of continuing 
interest in the nutritional sciences because of the relatively high frequency of iron deficiency 
anemia and the remarkably poor efficiency of absorption of most forms of dietary iron. 
 The availability of the iron in plant foods such as beans, peas, corn, bread and rice is 
quite poor. It ranges from less than 1 % to 10 %. The availability of iron in the meat is 
considerably higher than that in plant products. The non-heme iron in meat, fish, chicken and 
liver may be about 20 % available. The heme-iron of meat may be close to 30 % available. 
Nearly all of the iron in plants is non-heme iron.  
  The term availability describes the percentage of the iron in the food which is 
absorbed and used for physiological purposes, such as red blood cell formation.  
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The interactions between different foods have sparked some interest. For example, if rice is 
consumed with orange juice, the orange juice can enhance the absorption of iron in the rice. 
This effect results from the chelation of the iron by the ascorbate in the juice and the 
increased absorbability of the iron from the complex.  
On the other hand, Sandberg (2002) reported that, if rice is consumed with tea, the 
tannins in the tea can reduce the absorption of the iron in the rice because the iron in the 
iron-tannin complex is not readily available.  
  In general, including meat in the diet can increase the availability of iron from other 
foods. The mechanism of this effect is not clear. Also, phytic acid has been identified as a 
major inhibitor of iron absorption in plant foods.   
 The mineral content of legumes is generally high, but the bioavailability is poor due 
to the presence of phytate, some legumes also contain considerable amount of iron-binding 
polyphenols inhibiting iron absorption. It has been demonstrated that nutritional iron 
deficiency reaches its greatest prevalence in populations subsisting on cereal and legume 
basal diet.   
 
1.10.2. Example of plants containing iron: 
As stated in the Phytochemeco database (James et al, 1998) 
1. Taraxacum officinale WIGG.-Dandelion (Leaf) 500-5,000PPm (From Czech Republic) 
2. Echinacea spp-Coneflower (Root) 700-4,800ppm. (Italia plants) 
3. Artemisia vulgaris L.-Mugwort (Plant) 1,200-3,900ppm. (Chinese plant) 
4. Physalis ixocarpa BROT.-Tomatillo (Fruit) 14-2,974ppm. (Mexican plant) 
5. Asiasarum sieboldii (MIQ.) MAEK. – Siebold's Wild Ginger (Root) 450-2,800ppm. 
(Japanese plant) 
6. Carthamus tinctorius L.-Safflower (Flower) 81-2,200ppm. (American plant) 
7. Nyssa sylvatica MARSHALL- Black Gum (Leaf) 8-1,820 ppm. (American plant) 
8. Schizonepeta tenuifolia BRIQ.- Ching- Chieh (Plant) 1,700ppm. (Chinese plant) 
9. Amaranthus sp.-pigweed (Leaf) 23-1,527ppm. (Origion is Himalaya) 
10. Camellia sinensis (L.)KUNTZE – Tea (Leaf) 189- 1,500 ppm. (South and South East 
Asia) 
11. Arctium lappa L. Gobo (Root) 8-1,470ppm. (American plant) 
12. Nepeta cataria L. - Catnip (Plant) 1,380ppm. (Found in Europe, Africa, Asia and North 
America) 
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13. Juniperus Virginia L.-Red Cedar (Shoot) 11- 1,320ppm. (American plant) 
14. Polygonum cuspidatum Slebold & Zucc. Japanese Knotweed (plant) 360-1.300 ppm. 
(Japanese plant) 
15. Senna occidentalis (L.) Erwin H. & Barenby- Coffee Senna (Seed) 1.300 ppm. (Pacific 
Areas) 
 
1.11. Treatment of anemia with plants extracts: 
Jin et al, (1998) carried out studies to detect the effects of medicinal plants on 
hemorrhagic anemia. One of these is the effects of hairy root Huangqi on hemopoietic 
system. The oral administration of 5-20 gm/kg per day for 5-12 days could increase the 
count of RBC and reticulocytes in mice with hemorrhagic anemia raise the hemoglobin, 
RBC and PCV in mice with hemolytic anemia, enhance the number of WBC and nucleated 
cells in bone marrow of mice treated with X-ray.  
Another study conducted by Hatono et al, (2004) revealed that the extract from the 
root of Angelica acutiloba Kitagawa, which is used as herbal medicine in Japan, was found 
to be clinically effective for postmenstrual blood loss and erythropoietin-resistant anemia. 
The results suggested the polysaccharides in this plant promote hematopoiesis by activating 
immature erythroid cells in mice with 5- fluorouracil-induced anemia.  
The effect of pollen and propolis produced by bees was studied by using these 
natural products to the diets and it was found to improve the digestive utilization of iron and 
the regeneration efficiency of hemoglobin, especially during recovery from an anemic 
syndrome. Furthermore, when used in iron- deficient rats, these natural products were found 
to lessen, to a large extent, the adverse effects of iron deficiency and to improve the digestive 
utilization of calcium and magnesium. (Haro et al, 2000)   
Feeding 437 children with fermented soya been for six months, significantly 
decreased the incidence of iron-deficiency anemia from 21.7 % to 1.25 %.The absorption 
rate(21.8 %) in the children given the diet containing fermented soya was significantly 
higher (14.2%) than that in children given control diet and about the same as that in the Fe 
SO4 group (22.48%). (Qin, 1998) 
 In another study conducted by Miller, (1998) anemic rats were fed diets containing 
adequate quantities of all required nutrients except iron, which was supplied by ferrus 
sulphate and / or corn grain. The results indicated that slopes of the regression lines for 
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response (hemoglobin concentration to ferrus sulphate intake) were not altered significantly 
by inclusion of up to 75 % corn in the diets, hence it was concluded that, corn diets do not 
contain an inhibitor of iron absorption.  
Furthermore, Pandit et al, (1999) has found that Ayurvedic preparations of metallic 
iron commonly categorized as different putas of Louha Bashma was chemically analyzed 
and pharmacologically investigated in iron deficiency anemia. The effect of a representative 
puta viz.50 puta of Louha Bashma in the management of induced iron-deficiency anemia in 
animal model was found to be statistically highly significant (P< 0.001) in comparison to the 
control and standard drug Fefol treated groups.  
Previous studies carried out by Sulieman and Eldoma (1994) has reported that 
Grewia. tenax was used to increase haemoglobin level and hence is for the treatment of 
anemia.   
Some plants were found to contain iron. Examples of these are Bridelia cathartica 
and Lannea stuhlmannii. Their iron content was determined by using atomic absorption 
spectrophotometry. Plant extracts were made by wet and dry procedures. The results 
obtained from both procedures agreed significantly and the average of both methods was 
taken as the iron content in each plant part. In most cases, the values obtained for the root 
bark had higher total iron contents of 35.69 and 35.21 mg/100g were found in the root bark 
of the above two plants respectively. The iron content of the decoctions prepared in the 
traditional way was low. However, the therapeutic potential of the herbs can not be 
established on basis of available iron content alone as other factors play a role in the 
absorption of iron in the body. (Omolo et al, 1997) 
The effect of administration of aqueous extract of Paraquetina nigrescens on 
hematological parameters was investigated by Agbor and Odetola (2001) in hemorrhagic 
anemic rats. The anemic rats were administered with 400mg/kg, 800mg/kg and 1600mg/kg 
of P. nigrescens aqueous extract daily for four weeks. Significant (P< 0.05), progressive and 
dose related increases were observed in red blood cell count, hemoglobin, PCV and 
reticulocyte. While a decrease in white blood cell count was observed in the test rats treated 
with the extract compared with both normal and bled control rats.  
A standard hemoglobin repletion bioassay was used with rats made anemic followed 
by complete diets containing equivalent amounts of iron as Fe SO4 or one of three different 
bioengineered rice varieties. Rice diets were as effective as the Fe SO4 diet in replenishing 
PCV, Hb concentration and liver iron concentrations. The found results suggested that 
Mendelian and biotechnological approaches to manipulating ferritin expression of seed iron 
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in rice may contribute to a sustainable solution to global problems of iron deficiency. (Laura 
et al, 2002) 
Recently, many medicinal plants were used in the treatment and correction of the 
various types of anemia.  A clinical trial was adopted to observe the therapeutic effect of 
shengxuening (SXN) in treating iron-deficiency anemia. Its effect in the treatment of iron-
deficiency anemia was evident. It could improve the iron metabolism, increase levels of Fe, 
transferrin saturation, serum ferritin and lower levels of TIBC and transferring. Ke et al, 
(2004) 
On the other hand, the effect of Toki-shakuyaku-san and iron preparation in- vivo in 
an animal experiment (anemic rats) was evaluated by Akase et al, (2004). The results 
showed trends toward improvement in indices of anemia i.e RBC count, Hb-level, PCV and 
serum iron. Also improvement of anemic symptoms in the groups treated with the plant only 
and/ or with iron preparation. It was concluded that by using Toki-shakuyaku-san and iron 
preparation in combination is possible to lessen the adverse reactions such as gastrointestinal 
symptoms, and that more ameliorative effect on the anemic state can be expected.  
 
1.12. Local plants used in the study: 
1.12.1. Hibiscus sabdarrifa: 
Family: Malvaceae 
English name: Roselle 
Local name: Kerkade 
In folk medicine, the beverage of H. sabdariffa is reported to be antiseptic, 
aphrodisiac, astringent, cholagogue, digestive, diuretic, emollient, purgative, refrigerant, 
resolvent, sedative, stomachic and tonic. Roselle is a folk remedy for abscesses, cancer, 
dedility, dyspepsia, dysuria, fever, heart ailments, hypertension, neurosis and scurvy. The 
drink made by placing the calyx in water, is said to be a folk remedy for cancer. Medicinally, 
leaves are emollient and are much used in Guinea as a diuretic, refrigerant and sedative.  It 
was found that using electrothermal atomic absorption spectrometry after  nitric/ perchloric 
digestion   revealed   that H.sabdarrifa infusion  could supply greater amounts of iron (111± 
5 µg/g total, 40.5 %  leached). (Wrobe and Urbina, 2002). 
Toxicological studies carried out by Akindahunsi and Olaleye (2003) on the aqueous 
fraction of an aqueous-alcohol extract of H.sabdarrifa L. calyces, revealed increased levels 
of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in all treated rat 
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groups compared to the controls. Prolong usage of this extract (250mg/kg) at 15-dose level 
could cause liver injury while the effect was mild at small dose levels (1-10). Though, the 
average consumption of 150-180 mg/kg per/day appears safe; the extract should be taken 
with caution bearing in mind that higher doses could affect the liver.  
 Also Rao (1996) has analyzed the seeds of H.sabdariffa  for their proximate 
composition. Protein (22.3 %), fat (22.8%) and dietary fibre (42.6%). The seeds were good 
sources of minerals like phosphorus, magnesium and calcium.   
Other study carried out by Rao (1996) revealed that the aqueous extract of 
H.sabdariffa showed a miracicidal and/or cercaricidal activity at a concentration of ≤ 10000 
ppm; and it was toxic at 50-100 ppm.  
On the other hand, the aqueous extract of the calyces of H.sabdariffa induced an 
estrogen- like activity in immature female rats when injected at 500mg/kg i.p. (El Sheikh et 
al, 1990). 
Toxicological studies carried out by Ali et al. (1989) for 3 months on the extract of 
H.sabdariffa seeds showed that they had no cytotoxic effect. It was concluded that the 
refreshing herbal drink made from roselle is safe for human consumption. 
Another study on the nutritional properties of Hibiscus sabdariffa seeds indicated 
that the whole seed flour contained 26.28, 20.13, 43.21 and 4.83 % respectively of protein, 
oil, carbohydrate and minerals. (Askari et al,1996) 
Further studies on the phytochemical, pharmacological and toxicological properties 
of Hibiscus sabdariffa showed strong in- vitro and iv-vivo anti-oxidant activity. In rats and 
rabbits, the extract showed antihypercholesterolemic, antinociceptive anti-pyretic, but not 
anti-inflammatory activities. In rat and man, a strong anti-hypertensive action has been 
demonstrated. The effects of the calyx extracts on smooth muscles in-vitro are variable, but 
they mostly inhibit the tone of the isolated muscles. In healthy men, consumption of 
H.sabdariffa has resulted in significant decreases in the urinary concentrations of creatinine, 
uric acid, citrate, tartrate, calcium, sodium, potassium and phosphate, but not oxalate. Oil 
extracted from the plant seeds has shown to have an inhibitory effect on some bacteria and 
fungi in-vitro. The plant extracts are characterized by a very low degree of toxicity. The LD 
50 of H.sabdariffa calyx extract in rats was found to b above 5000mg/kg. A single report has 
suggested that excessive doses for relatively long periods could have a deleterious effect on 
the testes of rats. (Abu Tarboush et al, 1997) 
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1.12.1.1. Chemistry of seeds of H. sabdariffa: [Table 2]  
Ali et al. (2005) has summarized the chemistry of seeds of H. sabdariffa in the following 
table:          
Moisture 7.6 % 
Crude protein 24% 
Fat 22.3 % 
Fibre 15.3 % 
N- free extract 23.9% 
                 
                        
 
1.12.1.2. Component acids of the seed lipids were: 
        2.1 % myristic, 35.2 % palmitic, 2 % palmitoleic, 3.4 % stearic, 34 %      oleic, 14.4 % linoleic 
and 3 unusual HBr- reacting fatty acids (cis-12, 13-epoxy- cis-9- octadecenoic (12,13- epoxoleic) 
4.5 %; sterculic, 2.9 % and malvalic, 1.3   %. (James, 1983)  
        On the other hand, Salma et al. (1979) has reported that the sterols in the seed oil are: 61.3 % 
ß-sitosterol, 16.5 %  campasterol, 5.1 % cholesterol and 3.2 % ergosterol (said to be rare in 
vegetable oil but the most common mycosterol in most fungi, including yeast).  
 
1.12.2. Azanza garckeana: 
Family: Malvaceae 
English name: African Chewing Gum. 
Local name: Jakjak. 
               James, (1983) repoted Azanza garckeana as a valuable edible indigenous fruit tree species 
that is widely distributed in east and southern Africa. The specific countries where the species is 
found are Botswana, Kenya, Malawi, Mozambique, Namibia, South Africa, Tanzania, Zambia and 
Zimbabwe. Palgrave, (1988) described the fruits of Azanza garckeana are divided into 4-5 sections. 
They are yellowish to brownish green and hairy when mature. Fruits are edible from August and 
they are the most useful source of Azanza garckeana. On the other hand, Mojeremane and 
Tshwenyane (2004) reported that the fruits are eaten while slightly green or when ripe. They are 
persistent, therefore are picked on ripening. They can be soaked in a small amount of water to make 
jelly and can also be boiled and used as relish or made into porridge.  Also Connelly et al. (1996) 
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stated that the aqueous and organic fractions from A. garckeana showed that this plant had a weak 
anti-malarial activity. Whereas Roy, et al (1992) stated that the solvent fractions of the heart wood 
of Azanza garckeana had yielded six naphthoquinones. These include mansonones E…H., azanzone 
B. and a new compound A, with structure 3,18 dimethyl 1-7-hydroxy-5-isopropyl 1-1,2-
naphthalenedione which has been established by spectroscopic methods.   
The edible portion of the wild fruit of Azanza garckeana was analyzed for moisture, protein, fat, 
crude fibre, ash and minerals (Ca, Mg, Fe, P, K and Na).The total carbohydrate and energy contents 
were also calculated. The highest level of fibre (45.3 %) was found on A. garckeana. The lowest 
level of energy value in A. garckeana and it was 810 KJ 100g -1. (Kalenga et al, 1994)  
 
1.12.2.1. Chemical Composition of Azanza garckeana : [Table 3]  
 
Saka et al, (1994) analyzed the chemical composition of Azanza garckeana in the following 
table: 
                            
Chemical composition Amount  
Dry matter 52.8 % 
pH 5.96 
Ascorbic acid (mg/100 gm of fresh 
weight) 
20.5 (1.8) 
Crude protein 12.0 % 
Fat 1.1 % 
Fibre 45.3 % 
Total carbohydrate 35.2 % 
Phosphorus 1476 (µg/g)  
Calcium 95 (µg/g) 
Magnesium 1453 (µg/g) 
Iron 84 (µg/g) 
Potassium 26190 (µg/g) 
Sodium 202 (µg/g) 
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                      Figure 2. Azanza garckeana Fruits.  
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                Figure 3. Azanza garckeana Tree 
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                   Figure 4. Grewia tenax Fruits 
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           Figure 5.Hibiscus sabdariffa Fruits and Seeds 
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1.12.3. Grewia tenax: (Forsk.) Fiori.: 
1.13.3.1. Taxonomy: 
Synonyms: Grewia betulifolia juss., Grewia populifolia vahl. 
 Family: Tiliaceae. 
 Local name: Gudeim. 
 
1.12.3.2. Description:  
Small tree or shrub, up to 2m high, with dark grey bark and minute white lenticles 
(which persist only for a very short period). Leaves small, 1.5-4 cm wide, dentate wrinkly, 
glabrous or pubescent. Flowers white, solitary, axillar, 1.5 cm. Fruit red when ripe, glabrous, 
smooth, between 1 and 4 lobes, the size of a maize kernel, 21.000 seeds/kg. Distribution: 
The northernmost of the Grewia species of the Sahel; frequent in the transitional zone to the 
Sahara but also in the South of Moroco and Algeria. From the Atlantic through semi-arid 
Africa; to Kenya, Somalia, Zambia. Btsowana, Namibia, on the Arabian Peninsula and Iran 
to India. (Maydell, 1986) 
 
1.12.3.3. Folk Uses: Fruits used for treatment of malaria and anemia. (El Gazali et al, 1998). 
Grewia tenax roots, leaves, juice and fruit decoctions have been used in Africa and 
Southeast Asiatic countries for a variety of medical purposes.   
 It is an acrid, orange fruit usually eaten raw. Leaves are boiled and eaten as 
vegetable. In the Sudan it is found in Western, Northern and Southern states. Fruits are eaten 
fresh, or dried for later consumption. A drink is prepared by soaking the fruit overnight, 
hand pressing, sieving and sweetening. A porridge called Nasha, is also flavored by this 
drink, by addition of custard and flour. 
 
1.12.3.4. Chemical composition: 
             The Fruits contains:  
             Protein (crude)               = 6.3 % (dry) 
             Fat                                  = 0.4 % (dry)    
             Fibre (crude)                  = 8.1 % (dry) 
             Ash                                 = 4.5 % (dry) 
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1.12.3.4.1. Carbohydrate (soluble):  
Starch= 15.1 % dry, Sucrose= 1.6 % dry, D- glucose= 21.0 % dry and D- Fructose= 24.3 % 
dry. 
1.12.3.4.2. Amino acids: 
Aspartic acid= 8.1 g, Threonine= 2.1 g, Serine= 2.4 g, Glutamic acid 6.2 g, Proline= 
11.6 G, Glycine= 3.5 g, Alanine= 2.4 g, Valine= 2.8 g, Cysteine=1g,        Methionine=  0.7 
g, Isoleucine= 2g, Leucine= 3.4 g, Tyrosine= 2.5 g, Phenylalanine= 2.2 g, Lysine= 2g, 
Histidine= 1.1 g and Arginine= 3.2 g. (Abdelmuti et al, 1991). 
1.12.3.4.3. Other constituents:  
Every 100gm of plant contains: 146mg of vitamin (C), 218mg calcium, 174mg     
magnesium and 1352mg of pottassium. (Rahmatalla, 1999) 
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2. MATERIALS AND METHODS 
 
 
2.1. Materials: 
2.1.1. Animals: 
Twenty five Wistar albino rats weighing between 140 g and 150 g were used in the 
hemorrhagic anemia model. While other twenty five male Wistar rats of 21 days of age were 
used in the nutritional anemia model. All of the rats were obtained from the animal house of 
Medicinal and Aromatic Plants Research Institute (MAPRI). The animals were acclimatized 
for 7 days in the Department of Pharmacology and Toxicology of (MAPRI) before 
experimentation. They were fed ad. Libitum on a standard diet prepared in the animal house 
of the institute.  
 
2.1.2. Chemical analysis of the rat diet: 
* Components:  
-Dry matter: 71.69% 
-Ash: 6.25% 
-Organic matter: 93.75% 
-Crude protein: 3.64% 
-Crude Fibre: 3.92% 
-Ether extract: 9.08% 
-Net free energy: 77.11% 
The analysis of the diet was made by: The environment and natural resources Research 
Institute- Medicinal and Aromatic Plants Research Institute (MAPRI)-National Center for 
Research-Khartoum-Sudan.   
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2.1.3. Plants: 
Seeds of Hibiscus sabdariffa were collected from the farm of (MAPRI) at Khartoum 
State where the plant was cultivated. While fruits of Azanza garckeana were collected from 
Kordofan State in western part of Sudan. The Grewia tenax fruits were purchased from local 
markets in Khartoum state. The three plants were authenticated by the taxonomists in 
(MAPRI).   
 
2.2. Methods: 
2.2.1. Method for determination of iron content of H. sabdariffa, Azanza 
garckeana, and Grewia tenax plants: 
 
The fruits of A. garckeana, seeds of H. sabdariffa and fruits of G. tenax were 
subjected to chemical analysis in order to evaluate the amount of some elements contained in 
them. Those elements were: iron, sodium, magnesium and calcium. The analysis was carried 
out by using atomic absorption spectrophotometeric (PERKIN-ELMER-2380. 
As stated by Allen, (1989) 0.5 g of air-dried sample of each of the three plants was 
weighed into acid washed porcelain basins. The samples were ignited at 5500C for 2 hours in 
a muffle furnace. Then they were cooled and 5 ml of 20 % HCl were added to each sample. 
They were covered with watch glass and heated on a steam bath for 15 minutes. To each 
sample, 1 ml of HNO3 was added, evaporated to dryness and heating was continued for 1 
hour to dehydrate silica. 1 ml of 20 % HCl was added, swirled to dissolve the residue and 
then diluted to 10 ml with water and warmed to complete dissolution. The samples were then 
filtered through a No. 44 filter paper into a 50 ml volumetric flask and diluted to volume. 
These samples were then read by using an atomic absorption spectrophotometer. 
 
2.2.2. Plant extraction: 
Plants of the study were dried in shades and coarsely ground. Then they were soaked 
in distilled water for overnight. The concentration of each extract was 50 % w/v. The 
aqueous extract of each plant was minced, filtered and kept at 4˚C for daily administration. 
This method of extraction was chosen according to the folk use of each plant in traditional 
medicine. Dose used in this study is 2g/kg body weight for each extract referring to the 
starting plant material. 
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2.2.3. Preparation of diets: 
 Two types of rats diets were used in these experiments. The first diet (A) contained 
39.15 mg Fe/kg diet. The source of iron in this diet was from animal protein. While diet (B), 
the iron deficient diet, contained 26.7 mg Fe/kg diet and the source of iron was from plant 
origin only. 
 
2.2.2.1. Determination of iron content in the diet: 
 1 gm of the ground powder of the rats' diet was weighed in a crucible and inserted in 
an oven of 500 ºC for 3 hours. 50 ml of 20 % HCl were added and then filtered in a 
volumetric flask. Washed with distilled water and then the volume was completed to 50 ml. 
All the organic matter is then converted to inorganic ions (Stewart, 1989). The samples were 
then taken to be read by atomic absorption, Perkin- Elmer, 2380.    
 
2.2.4. Hemorrhagic anemia model: 
The rats used in the hemorrhagic anemia experiments were divided into three groups 
of 5 rats in each group and labeled (A), (B), (C1), (C2) and (C3). The first group (A) was the 
normal un-bled group. They received distilled water only and served as the control un-bled 
group. Groups (B), (C1), (C2) and (C3) were bled 30 % off their total blood volume which is 
5-7 ml in each rat as described by the (Trevor and Robinson, 1988).  
24 hours after bleeding from orbital plexus of rats as described by Khanna et al. 
(1992), hematological parameters of the bled rats were determined and thus considered as 
the baseline of the hematology values.  
Immediately after bleeding, the second group (B) was administered with distilled 
water and served as the control bled group. While bled groups of (C1), (C2) and (C3) received 
a daily dose of 2 g/kg body weight of the aqueous extract of the studied plants.  
Animals in group (C1) were administered with 2g/kg body weight of the aqueous 
extract of Hibiscus sabdariffa seeds. While animals in group (C2) received 2g/kg body 
weight of Azanza garckeana aqueous extract. Group (C3) has received 2g/kg body weight of 
Grewia tenax aqueous extract.  
The administration of each extract continued for 28 consecutive days. Hematological 
parameters were measured on days 7, 14, 21 and 28 of experiment.  
  Hematological parameters studied were: Hb level, PCV level, MCV, MCH, MCHC 
and RBC count by using hematology auto-analyzer (Huma-Plus).    
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2.2.5. Nutritional anemia model: 
In the nutritional -anemia model,  rats of 21- days of age were fed with iron deficient 
diet (26.7 mg Fe/kg diet) for 28 consecutive days and continued feeding for another 4 weeks 
after the beginning of the experiment.  
The iron deficient rats were divided into four equal groups of five rats each. The first 
iron deficient group of rats (A), were given distilled water only and served as control iron 
deficient group. The second (B1), third (B2) and fourth (B3) iron deficient groups were 
administered with 2g/kg body weight of the aqueous extracts of: Hibiscus sabdariffa, Azanza 
garckeana and Grewia tenax respectively.   
The last group of rats (C) were fed with a normal iron-content diet (39.15 mg Fe/kg 
diet) and served as a control group with the normal diet.  
Hematological parameters studied were: Hb level, PCV level, MCV, MCH, MCHC 
and RBC count by using hematology auto-analyzer (Huma-Plus).     
 
2.2.6. Study of the effects of aqueous extracts of H. sabdariffa and A. 
garckeana on iron absorption: 
 
2.2.6.1. Protocol of extraction: 
 500 gm of each plant were ground and sifted. Boiling water was added and they were 
separately agitated for 90 minutes. The two plants were steeped for 4 hours at 4◦C and then 
filtered with a vacuum pump. They were evaporated and freeze-dried. 20 mg of each extract 
was used in the experiment.  
2.2.6.2. Treatment of animals: 
Experiments were carried out on male Wistar albino rats weighing between 150 and 
200gm. They had free access to water but food was withdrawn 24 hour prior to 
experimentation.  
 Animals were sacrificed by cervical dislocation and 3 cm length pieces of duodenum 
were immediately extracted, stripped of adhering tissue and cleaned with a Ringer solution 
(9%) contained the following salts( mmol/L) containing the following salts: 
 NaCl (0.154), KCl (0.0034), HCO3Na (0.0024) and CaCl2 (0.021).  
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2.2.6.3. Everted gut sacs: 
 The everted gut sacs were hanged in an incubatory medium containing 200Mmol/L 
of FeSO4. In the first preparation, there were the physiological solution and the FeSO4 only, 
and it was kept as a control preparation. In the second preparation there was 20mg/ml of H. 
sabdariffa extract. In the third preparation there was 20mg/ml of A. garckeana extract.  The 
three preparations were maintained at 37◦C and bubbled with O2. 
 
2.2.6.4. Iron determination: 
 Iron concentration was measured by using PERKIN- ELMER- 2380 atomic 
absorption spectrophotometer after 1, 5 and 15 minutes following the addition of the extracts 
and the FeSO4 solution.  
 
2.2.7. Statistical analysis: 
One-way analysis of variance (ANOVA) test was used for the analysis of data of this 
study by using SPSS version 10 program. The ANOVA test allows determining if one given 
factor has a significant effect on any of the groups under study.  
All data in the study were expressed as Mean ± SD. 
P-value 
Indicates the probability of getting a mean difference between the groups as high as what is 
observed by chance. In this study, P value was considered significant at P ≤ 0.05. 
  Dunnett's test compares group means. It is specifically designed for situations where 
all groups are to be pitted against one "Reference" group. Its goal is to identify groups 
whose means are significantly different from the mean of this reference group. This test was 
applied in this study.  
 
 
 
 
 
 
49 
 
3. RESULTS 
 
 
3.1. Determination of iron and copper contents of H. sabdariffa, 
Azanza garckeana, and Grewia tenax plants: 
 
 In this study, it was found that G. tenax had the highest amount of iron 8.8 mg Fe/ 
100 g pulp, while A. garckeana fruits contained 6.8 mg/100 g and the least amount of iron 
was found in H. sabdariffa (4.6 mg/100 gm pulp). On the other hand, the copper content was 
found to be 0.65 mg/100g in H. sabdariffa, 0.36 in G. tenax and 0.2 in A. garckeana. Hence, 
it was obvious that G. tenax had the highest amount of iron in the three plants, A. garckeana 
better than H. sabdariffa. These results may affect the use of the three plants in the treatment 
of iron-deficiency anemia with consideration of other factors affecting the absorption and 
bioavailability of iron.  
 
Table 4.  
Determination of iron and copper contents of H. sabdariffa, Azanza 
garckeana, and Grewia tenax plants: 
 
 
Groups 
 
Iron content (mg/ 100 
g pulp) 
 
Copper content (mg 
/100 g pulp) 
 
Hibiscus sabdariffa 
 
4.6 
 
0.65 
 
Azanza garckeana 
 
6.8 
 
0.2 
 
Grewia tenax 
 
8.8 
 
0.36 
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3.2. Effect of the tested extracts on hematological parameters of 
anemic rats 
 
3.2.1. The effect of H. sabdariffa aqueous extract on hemorrhagic anemic 
rats: 
 Administration of 2g/kg of H. sabdariffa aqueous extract to hemorrhagic 
anemic rats caused remarkable changes in their blood parameters. Those changes were found 
to be most obvious in terms of hemoglobin level and/or PCV values. This extract caused a 
distinguished increase of 26 % in the hemoglobin level of the hemorrhagic anemic rats after 
one week of treatment. That increase was compared to 12 % increase in the control bled rats 
and to a decrease of 10.9 % in the control unbled group. The increasing effect of the extract 
continued to be of 40 % after two weeks treatment compared to an increase of only 13.3 % 
in the control bled group. While the control unbled rats showed a decrease of 11 % in this 
week. 
In the third and fourth weeks of treatment, the increasing effect of the extract on the 
Hb level was slightly lower from that presented in the second week. It was estimated as 34 
% and 35 % in those two weeks respectively, compared to 29.4 % in the control bled rats 
and to 4 to 3.3 % in the control unbled group (table 5. and figure 6.) 
The PCV values showed similar changes in the Hb- levels. The extract caused 
remarkable increases in the PCV values throughout the period of treatment. These increases 
were estimated as 29 %, 39 %, 33 % and 33 % caused by H. sabdariffa extract in the first, 
second, third and fourth weeks of treatment respectively.  The control bled rats showed 
much lower increases throughout the period of experimentation. These increases were 
reported as 9.8 %. 2.4 %, 31 % and 21.6 % in the first, second, third and fourth weeks of 
experiment respectively. While the control unbled rats showed decreases of 14 and 18.6 % in 
the first two weeks of experiment and slight increases of 0.6 and 2.7 % respectively. Table 6. 
and figure 7. 
H. sabdariffa extract caused marked increases in the RBC counts of hemorrhagic 
anemic rats. These increases were estimated as 26.4 %, 36.9 %, 32.1 % and 32.6 % in the 
four weeks of the experiment respectively. These effects of the extract were compared to 
decreases in the control unbled group and an increase of less that 1 % in the first two weeks 
of experiment in the control bled group. Table 7. and figure 8. 
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The effect of H. sabdariffa extract on MCV levels of the anemic rats was reported as 
mild increases in the levels throughout the four weeks of the treatment. These increases of 
the treated group were estimated as 1.00, 0.72, 1.1 and 0.42 % in the four weeks respectively 
while the control groups have shown nearly similar increases in the MCV values. They were 
reported in the control bled group as 10, 1.3, 0.8 and 2.3 % increases in the MCV values in 
the four weeks of the experiment respectively (table 8.) 
H. sabdariffa extract showed low increases in the MCH and MCHC levels of the 
anemic rats. In the first week, it caused decreases of 1.2 % in the MCH values and of 3 % in 
the MCHC levels in the anemic rats compared to an increase of 12.8 % in the MCH levels 
and an increase of 2.3 % in the MCHC level of the control bled group.  
In the second week, the MCH level of the treated group was slightly increased (0.5 
%) compared to an increase of 11.7 % in the control bled group. However, the MCHC level 
of the treated group remained un-changed comparable to an increase of 10.3 % in the bled 
untreated group (table 9.) 
These alterations in the MCH and MCHC values continued to the last two weeks of 
the treatment. Evaluation of the MCH values revealed increases of 0.4 % and 1.2 % in the 
MCH levels of the treated group, compared to increases of 11.6 % and 3.7 % of the control 
bled group in the third and fourth weeks respectively. While changes in the MCHC levels 
were estimated as a decrease of 0.5 and an increase of 0.9 % in the treated group compared 
to increases of 10.1 % and 1.3 % in the control bled group at these last two weeks of the 
experiment respectively (table 10.) 
 
3.2.2. The effect of H. sabdariffa extract on iron- deficient rats: 
H. sabdariffa did not cause recognizable effects on the hemoglobin levels of the 
anemic, iron-deficient rats. The increase in the hemoglobin level was 0.96 % in the first 
week compared to an increase of 0.16 % caused by the control iron-deficient group. This 
increase in the hemoglobin level caused by H. sabdariffa extract was statistically significant 
at P< 0.05 when compared to the control normal diet group.  
In the second week, there were slight decreases in the treated and control groups. It 
was found to be 2.9 % in the treated group, 3.8 % in the control iron-deficient group and 3.7 
% in the control with the normal iron-content diet group. Table 11. and figure 9.  
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The increases in the PCV values in the first week were 1.9 % in the treated group, 0.6 
% in the control iron-deficient group whereas, the normal diet group showed a decrease of 
2.4 % in the PCV level.  
In the second week, the three groups showed variable decreases in their PCV levels. 
It was estimated as 0.3 % in the treated group, 2.3 % in the control iron-deficient group and 
7.3 % in the control with the normal iron- content diet. Table 12. and figure 10.  
The MCV levels were increased slightly in the first and second weeks. These 
increases were 0.17 % and 0.7 % caused by H. sabdariffa group in the first and second 
weeks respectively. However, these increases were not statistically significant. The control 
iron-deficient group showed increases of 2.5 % and 1.7 % in those two weeks respectively. 
Table 13.and figure 11.   
There were decreases in the MCH levels of H. sabdariffa group estimated by 0.75 % 
and 1.8 % in the first two weeks of experimentation. While the control iron-deficient group 
showed slight increases of 2.1 % and 0.1 % in the same weeks. Table 14. and figure 12.  
Treated and control iron-deficient groups showed slight decreases in their MCHC 
levels. These decreases were lower in the control iron-deficient rats estimated by 0.4 % and 
1.5 % in the first and second weeks respectively. However, the H. sabdariffa group has 
shown decreases of 0.8 % and 2.5 % in the same weeks. These differences in the MCHC 
levels were found to be statistically significant at P < 0.05 when compared to the two control 
groups. Table 14. and figure 12.  
The extract caused a slight increase in the RBC count in the first and third weeks of 
the experiment (1.6 % and 4.6 % respectively). These increases were met by decreases in the 
control iron-deficient rats (1.8 % and 2.4 % respectively). However, these increases were not 
statistically proven. Table 13. 
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Table 5. 
The effect of aqueous extract of Hibiscus sabdariffa on Hb- level (g/dl): 
 
Weeks 
Control un-bled 
group 
Control bled 
group 
Hibiscus sabdariffa group 
Week 0 13.46 ± 0.46 10.6 ± 1.56 9.8 ± 1.4  
Week 1 12 ± 1.96 11.88 ± 0.67 12.4 ± 1.02 
Week 2 11.98 ± 0.31 12 ± 0.21 13.76 ± 0.82  
Week 3 14 ± 2 15.4 ± 0.55 13.16 ± 0.8 
Week 4 13.9 ± 0.5 13.72 ± 0.55 13.28 ± 1.1  
 
(All data are expressed in mean ± SD) 
 
 
 
Table 6. 
The effect of aqueous extract of Hibiscus sabdariffa on PCV level (%): 
 
Weeks 
Control un-bled 
group 
Control bled 
group 
Hibiscus sabdariffa group 
Week 0 44.34 ± 4.01 35.28 ± 5.5 39.94 ± 2.9 
Week 1 38.14 ± 6.5 38.72 ± 3.2 43.02 ± 2.13 
Week 2 36.1 ± 0.78 36.14 ± 0.55 41.32 ± 2.13 
Week 3 44.62 ± 1.56 46.22 ± 1.76 41.32 ± 2.4  
Week 4 45.52 ± 1.7 45.02 ± 2.1 41.18 ± 2.6 
 
(All data are expressed in mean ± SD) 
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Table 7. 
The effect of aqueous extract of Hibiscus sabdariffa on RBC count (×106 µL): 
 
Weeks 
Control un-bled 
group 
Control bled
group 
Hibiscus sabdariffa group 
Week 0 7.58 ± 0.78 5.97 ± 1.02 5.04 ± 0.5  
Week 1 5.88 ± 0.1 6.03 ± 0.28 6.37 ± 0.26 
Week 2 6.1 ± 0.1 6.03 ± 0.28 6.9 ± 0.26* 
Week 3 7.53 ± 0.29 7.75 ± 0.46 6.66 ± 0.37 
Week 4 7.61 ± 0.27 7.44 ± 0.51 6.68 ± 0.4  
(All data are expressed in mean ± SD) 
*: significant at P < 0.05 
Table 8. 
The effect of aqueous extract of Hibiscus sabdariffa on MCV level hemorrhagic anemic rats 
(fL): 
 
Weeks 
Control un-bled 
group 
Control bled 
group 
Hibiscus sabdariffa group 
Week 0 58.58 ± 0.91 59.24 ± 1.75 61.44 ± 0.21 
Week 1 65.04 ± 9.3 65.22 ± 2.66 62.64 ± 2.6 
Week 2 59.18 ± 1.8 60.02 ± 2.04 61.88  ± 1.9 
Week 3 59.28 ± 1.57 59.72 ± 1.89 62.06 ± 2.5 
Week 4 59.84 ± 1.34 60.58 ± 1.61 61.7 ± 2.6 
(All data are expressed in mean ± SD) 
Table 9. 
The effect of aqueous extract of Hibiscus sabdariffa on MCH level  (Pg): 
 
Weeks 
Control un-bled 
group 
Control bled 
group 
Hibiscus sabdariffa group 
Week 0 17.88 ± 1.5 17.82 ± 0.77 19.68 ± 0.8 
Week 1 20. 46 ± 2.9 20.1 ± 1.75 19.44 ± 0.98 
Week 2 19.62 ± 0.69 19.9 ± 0.78 19.78 ± 0.8  
Week 3 18.52 ± 2.29 19.88 ± 0.56 19.76 ± 0.84 
Week 4 18.26 ± 0.44 18.48 ± 0.61 19.9 ± 1.9  
(All data are expressed in mean ± SD) 
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Table 10. 
The effect of aqueous extract of Hibiscus sabdariffa on MCHC (g/dl) level: 
 
Weeks 
Control un-bled 
group 
Control bled 
group 
A. garckeana
group 
Week 0 30.52 ± 2.1 30.1 ± 0.7 32 ± 1.1 
Week 1 31.46 ± 4.4 30.78 ± 2.18 31.02 ± 0.44 
Week 2 33.18 ± 0.33 33.14 ± 0.21 32 ± 0.73 
Week 3 31.32 ± 3.85 33.14 ± 0.21 31.85 ± 0.56 
Week 4 30.54 ± 0.15 30.48 ± 0.43 32.28 ± 2 
 
(All data are expressed in mean ± SD) 
 
Table 11. 
Effect of Hibiscus sabdariffa aqueous extract on Hb level of iron-deficient rats (g/dl): 
 Normal diet 
group 
Deficient diet group Hibiscus sabdariffa 
group 
Week 0 13.72 ± 0.19 12.18 ± 0.59 12.52 ± 0.86  
Week 1 13.32 ± 0.44 * 12.2± 12.2 12.64 ± 1.1 * 
Week 2 12.72 ± 0.31 11.72 ± 0.68 12.16 ± 0.95 
Week 3 13.9 ± 0.52 12.04 ± 1.13 12.74 ± 0.65 
(Data are expressed in Mean SD) 
*: statistically significant at p< 0.05 
Table 12. 
Effect of Hibiscus sabdariffa aqueous extract on PCV level of iron-deficient rats (%): 
 Normal diet 
group 
Deficient diet group Hibiscus sabdariffa 
group 
Week 0 42.9 ± 1.36 36.76 ± 2.04 38.46 ± 2.6 
Week 1 41.88 ± 1.93 37 ± 3.21 39.18 ± 3.5 
Week 2 39.76 ± 1.24 35.9 ± 2.5 38.34 ± 3.2 
Week 3 42.44 ± 1.6 36.08 ± 3.9 39.24 ± 2.5 
(Data are expressed in Mean ± SD) 
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Table 13. 
Effect of Hibiscus sabdariffa aqueous extract on RBC count of iron-deficient rats 
(×106/µL): 
Weeks Normal diet 
group 
Deficient diet group Hibiscus sabdariffa 
group 
Week 0 7.062 ± 0.36 6.61 ± 0.3 6.69 ± 0.41 
Week 1 6.822 ± 0.27 6.492 ± 0.5 6.8 ± 0.51 
Week 2 6.66 ± 0.22 6.358 ± 0.52 6.6 ± 0.52 
Week 3 7.128 ± 0.22 6.446 ± 0.68 7 ± 0.48 
(Data are expressed in Mean SD) 
 
Table 14. 
Effect of Hibiscus sabdariffa aqueous extract on MCV (fL) level of iron-deficient rats: 
Weeks Normal diet 
group 
Deficient diet group Hibiscus sabdariffa 
group 
Week 0 60.3 ± 2.3 55.6 ± 0.86 57.48 ± 1.5 
Week 1 61.42 ± 2.96 56.98 ± 1.03 57.58 ± 1.56 
Week 2 59.7 ± 0.7 56.52 ± 1.55 57.88 ± 1.7  
Week 3 59.54 ± 0.7 55.98 ±1.26 56.12 ± 1.3 
(Data are expressed in Mean ± SD) 
Table 15. 
Effect of Hibiscus sabdariffa aqueous extract on MCH level of iron-deficient rats (Pg): 
 
Weeks Normal diet 
group 
Deficient diet group Hibiscus sabdariffa 
group 
Week 0 19.48 ± 0.81 18.44 ± 0.36 18.72 ± 0.46 
Week 1 19.54 ± 0.87 18.82 ± 0.33 18.58 ± 0.83 
Week 2 19.1 ± 0.4 18.46 ± 0.49 18.38 ± 0.38 
Week 3 19.5 ± 0.35 18.72 ± 0.75 18.24 ± 0.56 
(Data are expressed in Mean ± SD) 
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Table 16. 
Effect of Hibiscus sabdariffa aqueous extract on MCHC level of iron-deficient rats (g/dl): 
 
 Normal diet 
group 
Deficient diet group Hibiscus sabdariffa 
group 
Week 0 31.98 ± 0.78 33.16 ± 0.76 32.54 ± 0.6 
Week 1 31.84 ± 0.52 * 33.02 ± 0.59 32.28 ± 1.2 * 
Week 2 32.02 ± 0.63 * 32.66 ± 0.54 31.74 ± 0.69* 
Week 3 32.76 ± 0.18 33.42 ± 0.8 32.48 ± 0.5 
 
(Data are expressed in Mean ± SD) 
• : statistically significant at P< 0.05 
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Figure 6. Effect of H. sabdariffa on Hb-level of hemorrhagic anemic rats 
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Figure 7. Effect of H. sabdariffa on PCV level of hemorrhagic anemic rats 
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Figure 8. Effect of H. sabdariffa on RBC count of hemorrhagic anemic rats 
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Figure 9. Effect of H. sabdariffa on Hb- level of iron-deficient rats 
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Figure 10. Effect of H. sabdariffa on PCV level of iron-deficient rats 
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Figure 11. Effect of H. sabdariffa on RBC count of iron-deficient rats 
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Figure 12. Effect of H. sabdariffa on MCV level of iron-deficient rats 
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Figure 13. Effect of H. sabdariffa on MCH level of iron-deficient rats 
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Figure 14. Effect of H. sabdariffa on MCHC level of iron-deficient rats 
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3.2.3. The effect of A.garckeana aqueous extract on hemorrhagic anemic 
rats: 
 
It was found that administration of (2g/kg) of Azanza garckeana aqueous extract 
caused remarkable changes in the blood indices of hemorrhagic anemic rats. This extract 
caused an increase in the Hb level of the hemorrhagic anemic rats on the first and second 
weeks of treatment (27.5 % and 39.4 % of increase respectively) compared to the control 
groups (bled and un-bled). This increase was statistically significant at P< 0.05; results are 
shown in table 17. and figure 15. 
On the third week of treatment, the treated group and the control bled group attained 
normal hemoglobin levels compared with the control un-bled group.  
 The A. garckeana extract showed non significant increases in the PCV levels as 
attained in the hemoglobin levels. The increases in the PCV values were found to be 32.8 % 
and 43.8 % in the first and second weeks of treatment respectively compared to that of the 
control bled group (statistically significant at P< 0.05). 
In the third week, the PCV levels of the treated group and the control un-bled group 
were nearly the same. 
In the fourth week, all of the groups (treated and controls) attained normal levels of 
PCV. Table 18. and figure 16. 
The red blood cell count was affected largely by the administration of the A. 
garckeana extract. It caused a significant increase (P < 0.005) in the first and second weeks 
of treatment that was estimated by 29.4 % and 36 % respectively. However, on the third and 
fourth weeks of treatment, the three groups showed stable and nearly equal levels of red 
blood cell counts (table 19. and figure 17.)  
The values of the mean cell volume (MCV) in the control bled group were elevated 
remarkably (10.1 %) in the first week of experiment. However, the A. garckeana group 
showed a much lower increase in the MCV values that was estimated by 2.4 %. The control 
un-bled group showed an increase of 11 % in the first week. 
In the fourth week, the MCV values of the control bled group were elevated slightly 
by 2.3 %, whereas, in the treated group the MCV values has returned to the same level that 
was shown before treatment. Table 20. 
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The control bled and un-bled groups showed variable increases in the mean cell 
hemoglobin values (MCH) in the first week of the experiment. These increases were 
estimated as 12.8 % and 14.4 % respectively. 
The A. garckeana extract caused a reduction in the MCH level (1.26 %), however, 
this was not statistically significant.  
In the third week, the MCH of the control bled group continued to increase by 11.6 
% while the A. garckeana group, caused a decrease of 3.6 %. Table 21. 
On the other hand, the A.garckeana caused a reduction in the MCHC level on the 
second week of treatment (3.4 %). While in the control bled rats, there was an increase of 
10.3 %. 
In the third week, the reduction in the treated group continued and this reduction was 
7.4 %, whereas, the increase in the control bled group was found 10.1%. Table 22. 
 
3.2.4. The effect of A. garckeana aqueous extract on iron-deficient rats: 
 
In the second type of experiments, the effect of A. garckeana aqueous extract was 
studied in nutritionally iron- deficient rats. After determining the basal hematological values 
of the nutritionally anemic rats, the treatment with the extract commenced.  
The Hb level, PCV, MCV, MCH, MCHC and RBC counts were determined on days 
7, 14 and 21 of the treatment. Multiple comparisons were made between the treated group, 
the control un-treated group and another control group that was fed with a normal iron 
content diet (39.15 mg Fe/ kg diet). 
The A. garckeana extract did not show any obvious alterations in the hematological 
parameters of the nutritionally iron deficient rats. By contrast, this extract was found to 
cause disadvantageous effects in the second and third weeks of treatment. It caused a 
decrease of 15.2 % in the Hb values in the second week compared to 3.8 % decrease in the 
Hb values of the control iron deficient rats. This unfavorable effect continued to the third 
week when a decrease of 5.3 % was observed in the treated group, compared to a decrease of 
0.12 % in the control group that was fed with the iron deficient diet. In this week, the control 
rats fed with the normal diet showed a decrease of 1.3 % in the Hb level. Table 23. and 
figure 18. 
Despite the above results, the extract possessed advantageous effects on the RBC 
counts of the anemic rats, although this effect was shown lately in the third week of 
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treatment. It caused an increase of 2.8 % in the RBC count compared to an increase of 1 % 
in the normal diet rats and a decrease of 2.4 % in the iron deficient ones.  However, this 
increase in the treated group was not statistically significant. Table  25. and figure 23.  
Evaluating other blood indices, revealed that A. garckeana extract had caused an 
increase of 2.1 % in the MCV level in the second week of treatment, compared to an 
increase of 1.7 % attained by the control iron deficient group. However, this increase 
attained by the treated group was not consistent because it changed to a decrease of 4.2 % in 
the third week of treatment. Table 26. and figure 20. 
The MCH levels of the treated group showed decreases of 5.1 % and 8.3 % in the 
second and third weeks of treatment respectively, compared to increases of 0.1 % and 1.5 % 
in the control iron- deficient group. 
These decreases in the MCH values were followed with decreases in the MCHC levels. The 
extract caused decreases of 6.6 % and 4.3 % in the second and third weeks of treatment 
respectively compared to 1.5 % decrease and 0.8 % increase in the control iron deficient rats 
in the same weeks. Table 27. and figure 21.  
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Table 17. 
The effect of aqueous extract of Azanza garckeana on Hb level of (g/dl): 
 
Weeks 
Control un-bled 
group 
Control bled 
group 
A. garckeana
group 
Week 0 13.46 ± 0.46 10.6 ± 1.56 10.92 ± 1.86 
Week 1 12 ± 1.96 11.88 ± 0.67 13.92 ± 1.12 
Week 2 11.98 ± 0.31 12 ± 0.21 15.22 ± 1.67 
Week 3 14 ± 2 15.4 ± 0.55 14.28 ± 1.34 
Week 4 13.9 ± 0.5 13.72 ± 0.55 14.5 ± 0.9 
(All data are expressed in mean ± SD) 
 
Table 18. 
The effect of aqueous extract of Azanza garckeana on PCV level (%): 
 
Weeks 
Control un-bled 
group 
Control bled 
group 
A. garckeana
group 
Week 0 44.34 ± 4.01 35.28 ± 5.5 33.28 ± 5.95 
Week 1 38.14 ± 6.5 38.72 ± 3.2 44.18 ± 2.05 
Week 2 36.1 ± 0.78 36.14 ± 0.55 47.86 ± 3.8 
Week 3 44.62 ± 1.56 46.22 ± 1.76 46.88 ± 3.13 
Week 4 45.52 ± 1.7 45.02 ± 2.1 43.58 ± 2.47 
(All data are expressed in mean ± SD) 
 
Table 19. 
The effect of aqueous extract of Azanza garckeana on RBC count (×106µL): 
 
Weeks 
Control un-bled 
group 
Control bled
group 
A. garckeana
group 
Week 0 7.58 ± 0.78 5.97 ± 1.02 5.72 ± 0.9 
Week 1 5.88 ± 0.1 6.03 ± 0.28 7.4 ± 0.31* 
Week 2 6.1 ± 0.1 6.03 ± 0.28 7.78 ± 0.58 
Week 3 7.53 ± 0.29 7.75 ± 0.46 7.76 ± 0.38 
Week 4 7.61 ± 0.27 7.44 ± 0.51 7.44 ± 0.62 * 
(All data are expressed in mean ± SD)  
* : significant at P < 0.05 
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Table 20. 
The effect of aqueous extract of Azanza garckeana on MCV level (fL): 
 
Weeks 
Control un-bled 
group 
Control bled 
group 
A. garckeana
group 
Week 0 58.58 ± 0.91 59.24 ± 1.75 58.04 ± 3.24 
Week 1 65.04 ± 9.3 65.22 ± 2.66 59.78 ± 2.77 
Week 2 59.18 ± 1.8 60.02 ± 2.04 61.56 ± 3.32 
Week 3 59.28 ± 1.57 59.72 ± 1.89 60.44 ± 3.13 
Week 4 59.84 ± 1.34 60.58 ± 1.61 58.74 ± 2.45 
(All data are expressed in mean ± SD) 
Table 21. 
The effect of aqueous extract of Azanza garckeana on MCH level (Pg): 
 
Weeks 
Control un-bled 
group 
Control bled 
group 
A. garckeana
group 
Week 0 17.88 ± 1.5 17.82 ± 0.77 10.08 ± 1.34 
Week 1 20. 46 ± 2.9 20.1 ± 1.75 18.84 ± 1.43 
Week 2 19.62 ± 0.69 19.9 ± 0.78 19.56 ± 1.58 
Week 3 18.52 ± 2.29 19.88 ± 0.56 18.4 ± 1.16 
Week 4 18.26 ± 0.44 18.48 ± 0.61 19.56 ± 1.07 
(All data are expressed in mean ± SD) 
 
 
Table 22. 
The effect of aqueous extract of Azanza garckeana on MCHC level (g/dl): 
 
Weeks 
Control un-bled 
group 
Control bled 
group 
B. garckeana
group 
Week 0 30.52 ± 2.1 30.1 ± 0.7 32.84 ± 0.69 
Week 1 31.46 ± 4.4 30.78 ± 2.18 31.46 ±1.11 
Week 2 33.18 ± 0.33 33.14 ± 0.21 30.42 ± 0.83 
Week 3 31.32 ± 3.85 33.14 ± 0.21 30.42 ± 0.83 
Week 4 30.54 ± 0.15 30.48 ± 0.43 33.26 ± 0.66 
 
(All data are expressed in mean ± SD 
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Table 23. 
Effect of A.garckeana aqueous extract on Hb level of iron-deficient rats: 
 
Weeks 
Normal diet 
group 
Deficient diet group A.garckeana group 
Week 0 13.72 ± 0.19 12.18 ± 0.59 12.42 ± 0.48 
Week 1 13.32 ± 0.44 12.2± 12.2 12.1 ± 1.1 
Week 2 12.72 ± 0.31 11.72 ± 0.68 10.525 ± 0.79 
Week 3 13.9 ± 0.52 12.04 ± 1.13 11.76 ± 1.83 
(Data are expressed in Mean SD) 
 
Table 24. 
Effect of A.garckeana aqueous extract on PCV level of iron-deficient rats: 
 
Weeks 
Normal diet 
group 
Deficient diet group A. garckeana group 
Week 0 42.9 ± 1.36 36.76 ± 2.04 37.92 ± 1.6  
Week 1 41.88 ± 1.93 37 ± 3.21 36.88 ± 3.6 
Week 2 39.76 ± 1.24 35.9 ± 2.5 34.475 ± 2.1 
Week 3 42.44 ± 1.6 36.08 ± 3.9 37.4 ± 4.1 
(Data are expressed in Mean SD) 
 
Table 25. 
Effect of A.garckeana aqueous extract on RBC count of iron-deficient rats: 
 
Weeks 
Normal diet 
group 
Deficient diet group A.garckeana group 
Week 0 7.062 ± 0.36 6.61 ± 0.3 6.698 ± 0.45 
Week 1 6.822 ± 0.27 6.492 ± 0.5 6.498 ± 0.58 
Week 2 6.66 ± 0.22 6.358 ± 0.52 5.9725 ± 0.51 
Week 3 7.128 ± 0.22 6.446 ± 0.68 6.886 ±0.7 
(Data are expressed in Mean SD) 
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Table 26. 
Effect of A.garckeana aqueous extract on MCV level of iron-deficient rats: 
 
Weeks 
Normal diet 
group 
Deficient diet group A.garckeana group 
Week 0 60.3 ± 2.3 55.6 ± 0.86 56.64 ± 1.56 
Week 1 61.42 ± 2.96 56.98 ± 1.03 56.72 ± 1.56 
Week 2 59.7 ± 0.7 56.52 ± 1.55 57.85 ± 2.9 
Week 3 59.54 ± 0.7 55.98 ±1.26 54.28 ± 1.48 
 (Data are expressed in Mean SD) 
Table 27. 
Effect of A.garckeana aqueous extract on MCH level of iron-deficient rats: 
 
 
Weeks 
Normal diet 
group 
Deficient diet group A.garckeana group 
Week 0 19.48 ± 0.81 18.44 ± 0.36 18.58 ± 0.54 
Week 1 19.54 ± 0.87 18.82 ± 0.33 17.9 ± 1.1 
Week 2 19.1 ± 0.4 18.46 ± 0.49 17.675 ± 1.75 
Week 3 19.5 ± 0.35 18.72 ± 0.75 17.04 ± 1.4 
(Data are expressed in Mean SD) 
 
Table 28. 
Effect of A.garckeana aqueous extract on MCHC level of iron-deficient rats: 
 
Weeks 
Normal diet 
group 
Deficient diet group A.garckeana group 
Week 0 31.98 ± 0.78 33.16 ± 0.76 32.76 ± 0.45 
Week 1 31.84 ± 0.52 33.02 ± 0.59 31.58 ± 1 
Week 2 32.02 ± 0.63 32.66 ± 0.54 30.6 ± 3.2 
Week 3 32.76 ± 0.18 33.42 ± 0.8 31.34 ± 1.9 
 
(Data are expressed in Mean SD) 
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Figure 15. Effect of A. garckeana on Hb- level of hemorrhagic anemic rats 
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Figure 16. Effect of A. garckeana on PCV level of hemorrhagic anemic rats 
 
 
 
72 
 
0
1
2
3
4
5
6
7
8
9
week 0 week 1 week 2 week 3 week 4
Weeks
R
B
C
 c
ou
nt un-bled
bled
A.garckeana
 
Figure 17. Effect of A. garckeana on RBC count of hemorrhagic anemic rats 
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Figure 18. Effect of A. garckeana on Hb-level of iron-deficient rats 
 
73 
 
 
 
 
0
5
10
15
20
25
30
35
40
45
50
week 0 week 1 week 2 week 3
Weeks
PC
V 
le
ve
l
normal diet
deficient diet
Jakjak
 
Figure 19. Effect of A. garckeana on PCV level of iron-deficient rats 
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Figure 20. Effect of A. garckeana on MCV level of iron-deficient rats 
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Figure 21. Effect of A. garckeana on MCH level of iron-deficient rats 
 
 
29
29.5
30
30.5
31
31.5
32
32.5
33
33.5
34
week 0 week 1 week 2 week 3
Weeks
M
C
H
C
 le
ve
l
normal diet
deficient diet
Jakjak
Figure 22. Effect of A. garckeana on MCHC level of iron-deficient rats 
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Figure 23. Effect of A. garckeana on RBC count of iron-deficient rats 
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3.2.5. The effect of Grewia tenax aqueous extract on hemorrhagic 
anemic rats: 
 
Administration of the aqueous extract of Grewia tenax to hemorrhagic anemic rats 
caused remarkable changes in their blood indices throughout the four weeks period of 
treatment.  
 The aqueous extract of G. tenax caused remarkable increases in the hemoglobin 
levels of the bled anemic rats throughout the experiment. These increases were estimated as 
26.5 %, 40.4 %, 34.4 % and 35.5 % in the first, second, third and fourth weeks of the 
experiment respectively, (Table 29. and figure 24. 
  These increases in the Hb levels of the treated rats coincided with other increases 
showed in their red blood cell counts.  
It was found that administration of G. tenax to the hemorrhagic anemic rats has 
caused increases of 26.4 %, 36.9 %. 32 % and 32.5 % in their blood cell counts in the first, 
second, third and fourth weeks of treatment respectively, table 30. and figure 25. 
However, the extract has been found to cause much less increases in the PCV values 
of these animals compared to those showed in the hemoglobin estimations and/or red blood 
cell counts. The increases in the PCV levels were estimated as 7.7%, 3.46 %, 3.46%4 and 
3.1 % in the first, second, third and fourth weeks of treatment respectively, table 31. and 
figure 26. 
 It was found that G. tenax aqueous extract has shown small increases in the MCV 
levels of the hemorrhagic anemic rat ( table 32.) These increases were estimated as 2 %. 0.7 
%, 1 % and 0.4 % increases on weeks 1, 2, 3, and 4 of the treatment respectively.  
On the other hand, G. tenax aqueous extract has shown small detectable changes in the MCH 
and MCHC values of these anemic bled rats. Tables (33. and 34.) 
 These changes were expressed as a decrease of 1.2 % in the first week of treatment. 
This decrease was followed by small increases of 0.5%, 0.4% and 1.1 % shown on the 
second, third and fourth weeks of the experiment respectively.  
 On the same pattern, G. tenax has caused a decrease of 3.2 % in the MCHC level in 
the first week of treatment whereas it has caused no change in the MCHC values of the 
second week of treatment. Then it was followed by a decrease of 0.5 % in the third week and 
an increase of 0.88 % in the last week of the experiment.  
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3.2.6. The effect of Grewia tenax aqueous extract on iron- deficient rats: 
 It was found that, administration of the aqueous extract of G. tenax to nutritionally 
anemic rats (iron- deficient rats) has caused remarkable changes in their blood indices. These 
changes were compared to those occurred to a group of control un -treated group that was 
also nutritionally anemic. 
 In the first week of treatment, G. tenax has caused an increase of 0.96 % in the Hb 
level of the anemic rats compared to an increase of only 0.16 % in the control un-treated 
group. However, this increase has changed to a decrease of 3 % in the second week of 
treatment in the G. tenax group compared to a decrease of 3.9 % in the control group in the 
same week. Table 35. and figure 27.  
 In the third week, the aqueous extract of G. tenax has caused an increase of 1.8 % 
compared to an increase of 1.2 % in the control rats.  
 The changes in the PCV values were found to follow almost the same pattern of 
changes that were shown in the first week; there were increases of 1.9 % and 0.65 % in the 
G. tenax and control groups respectively. While in the second week, there were decreases of 
0.3 % and 2.4 % in the treated and control groups respectively. In the third week, an increase 
of 2 % was detected in the G. tenax group compared to an increase of 1.9 % in the control 
un-treated group. Table 36. and figure 28. 
 Studies on the effect of the G. tenax aqueous extract on the red blood cell counts of 
the iron-deficient rats has shown that the extract has caused an increase of 1.6 % in the first 
week of treatment compared to a decrease of 1.8 % in the un-treated animals. Table 37. and 
figure 29. 
 In the second week, a decrease of only 1.4 % in the G. tenax group was detected 
comparable to a decrease of 4 % in the control group.  
 In the third week, while an increase of 4.6 % has been shown in the G. tenax group, a 
decrease of 2.5 % was detected in the control group.  
 G. tenax aqueous extract has shown small un-recognizable changes in the MCV 
levels of the anemic iron-deficient rats. The extract has caused small increase of 0.17 % in 
the MCV of the nutritionally anemic rats in the first week of treatment. The increase was 
found to be slightly higher in the second week (0.7 %) compared to a decrease of 0.14 % in 
the anemic un-treated group. However, in the third week of treatment there was a decrease of 
2.4 % shown in the G.tenax group that was compared to an increase of 0.7 % in the anemic 
un-treated animals. Table 38. and figure 30. 
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 Administration of G. tenax aqueous extract to nutritionally deficient rats has caused 
consistent decreases in the MCH levels of the rats throughout the three weeks of treatment 
on table 39. These decreases were 0.75 %, 1.9 % and 2.6 % shown in the first, second and 
third weeks respectively.  
 On the other hand, the control anemic group has shown increases of 2.1 %. 0.1 % and 
1.4 % in the three weeks of treatment respectively.  
 The effect of G. tenax aqueous extract on the MCHC levels of the iron- deficient rats 
was small and inconsistent. This extract has shown decreases of 0.8 %, 2.5 % and 0.18 % 
throughout the first, second and third weeks of experimentation respectively. These 
decreases were compared to other decreases of 0.4 % and 1.5 % and an increase of 0.8 % in 
the three weeks of experimentation in the anemic un-treated group on table 40. and figure 
31. 
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Table 29. 
The effect of aqueous extract of Grewia tenax on Hb level (g/dl): 
 
Weeks 
Control un-bled 
group 
Control bled 
group 
Grewia tenax group
Week 0 13.46 ± 0.46 10.6 ± 1.56 9.8 ± 1.4  
Week 1 12 ± 1.96 11.88 ± 0.67 12.4 ± 1.02 
Week 2 11.98 ± 0.31 12 ± 0.21 13.76 ± 0.82  
Week 3 14 ± 2 15.4 ± 0.55 13.16 ± 0.8 
Week 4 13.9 ± 0.5 13.72 ± 0.55 13.28 ± 1.1  
(All data are expressed in mean ± SD) 
Table 30. 
The effect of aqueous extract of Grewia tenax on RBC count (×106/µL): 
 
Weeks 
Control un-bled 
group 
Control bled
group 
Grewia tenax group
Week 0 7.58 ± 0.78 5.97 ± 1.02 5.04 ± 0.5  
Week 1 5.88 ± 0.1 6.03 ± 0.28 6.37 ± 0.26 
Week 2 6.1 ± 0.1 6.03 ± 0.28 6.9 ± 0.26 
Week 3 7.53 ± 0.29 7.75 ± 0.46 6.66 ± 0.37 
Week 4 7.61 ± 0.27 7.44 ± 0.51 6.68 ± 0.4  
(All data are expressed in mean ± SD) 
Table 31. 
The effect of aqueous extract of Grewia tenax on PCV level (%): 
 
Weeks 
Control un-bled 
group 
Control bled 
group 
Grewia tenax group
Week 0 44.34 ± 4.01 35.28 ± 5.5 39.94 ± 2.9 
Week 1 38.14 ± 6.5 38.72 ± 3.2 43.02 ± 2.13 
Week 2 36.1 ± 0.78 36.14 ± 0.55 41.32 ± 2.13 
Week 3 44.62 ± 1.56 46.22 ± 1.76 41.32 ± 2.4  
Week 4 45.52 ± 1.7 45.02 ± 2.1 41.18 ± 2.6 
(All data are expressed in mean ± SD) 
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Table 32. 
The effect of aqueous extract of Grewia tenax on MCV level (fL): 
 
Weeks 
Control un-bled 
group 
Control bled 
group 
Grewia tenax group
Week 0 58.58 ± 0.91 59.24 ± 1.75 61.44 ± 0.21 
Week 1 65.04 ± 9.3 65.22 ± 2.66 62.64 ± 2.6 
Week 2 59.18 ± 1.8 60.02 ± 2.04 61.88  ± 1.9 
Week 3 59.28 ± 1.57 59.72 ± 1.89 62.06 ± 2.5 
Week 4 59.84 ± 1.34 60.58 ± 1.61 61.7 ± 2.6 
(All data are expressed in mean ± SD) 
Table 33. 
The effect of aqueous extract of Grewia tenax on MCH level (Pg): 
 
Weeks 
Control un-bled 
group 
Control bled 
group 
Grewia tenax group
Week 0 17.88 ± 1.5 17.82 ± 0.77 19.68 ± 0.8 
Week 1 20. 46 ± 2.9 20.1 ± 1.75 19.44 ± 0.98 
Week 2 19.62 ± 0.69 19.9 ± 0.78 19.78 ± 0.8  
Week 3 18.52 ± 2.29 19.88 ± 0.56 19.76 ± 0.84 
Week 4 18.26 ± 0.44 18.48 ± 0.61 19.9 ± 1.9  
(All data are expressed in mean ± SD) 
 
Table 34. 
The effect of aqueous extract of Grewia tenax on MCHC level (g/dl): 
 
Weeks 
Control un-bled 
group 
Control bled 
group 
Grewia tenax group
Week 0 30.52 ± 2.1 30.1 ± 0.7 32 ± 1.1 
Week 1 31.46 ± 4.4 30.78 ± 2.18 31.02 ± 0.44 
Week 2 33.18 ± 0.33 33.14 ± 0.21 32 ± 0.73 
Week 3 31.32 ± 3.85 33.14 ± 0.21 31.85 ± 0.56 
Week 4 30.54 ± 0.15 30.48 ± 0.43 32.28 ± 2 
(All data are expressed in mean ± SD) 
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Table 35. 
Effect of Grewia tenax aqueous extract on Hb level of iron-deficient rats (g/dl): 
 
Weeks 
Normal diet 
group 
Deficient diet group Grewia tenax group 
Week 0 13.72 ± 0.19 12.18 ± 0.59 12.52 ± 0.86 
Week 1 13.32 ± 0.44 12.2± 12.2 12.64 ± 1.1 
Week 2 12.72 ± 0.31 11.72 ± 0.68 12.16 ± 0.95 
Week 3 13.9 ± 0.52 12.04 ± 1.13 12.74 ± 0.65 
 (Data are expressed in Mean ± SD) 
 
Table 36. 
Effect of Grewia tenax aqueous extract on PCV level of iron-deficient rats (%): 
 
Weeks 
Normal diet 
group 
Deficient diet group Grewia tenax group 
Week 0 42.9 ± 1.36 36.76 ± 2.04 38.46 ± 2.6 
Week 1 41.88 ± 1.93 37 ± 3.21 39.18 ± 3.5 
Week 2 39.76 ± 1.24 35.9 ± 2.5 38.34 ± 3.2 
Week 3 42.44 ± 1.6 36.08 ± 3.9 39.24 ± 2.5 
(Data are expressed in Mean ± SD) 
 
Table 37. 
Effect of Grewia tenax aqueous extract on RBC count (×106/µL) of iron-deficient rats: 
 
Weeks 
Normal diet 
group 
Deficient diet group Grewia tenax group 
Week 0 7.062 ± 0.36 6.61 ± 0.3 6.69 ± 0.41 
Week 1 6.822 ± 0.27 6.492 ± 0.5 6.8 ± 0.51 
Week 2 6.66 ± 0.22 6.358 ± 0.52 6.6 ± 0.52 
Week 3 7.128 ± 0.22 6.446 ± 0.68 7 ± 0.48 
(Data are expressed in Mean ± SD) 
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Table 38. 
Effect of Grewia tenax aqueous extract on MCV level of iron-deficient rats (fL): 
 
Weeks 
Normal diet 
group 
Deficient diet group Grewia tenax group 
Week 0 60.3 ± 2.3 55.6 ± 0.86 57.48 ± 1.5 
Week 1 61.42 ± 2.96 56.98 ± 1.03 57.58 ± 1.56 
Week 2 59.7 ± 0.7 56.52 ± 1.55 57.88 ± 1.7  
Week 3 59.54 ± 0.7 55.98 ±1.26 56.12 ± 1.3 
(Data are expressed in Mean ± SD) 
 
Table 39. 
Effect of Grewia tenax aqueous extract on MCH level of iron-deficient rats (Pg): 
 
Weeks 
Normal diet 
group 
Deficient diet group Grewia tenax group 
Week 0 19.48 ± 0.81 18.44 ± 0.36 18.72 ± 0.46 
Week 1 19.54 ± 0.87 18.82 ± 0.33 18.58 ± 0.83 
Week 2 19.1 ± 0.4 18.46 ± 0.49 18.38 ± 0.38 
Week 3 19.5 ± 0.35 18.72 ± 0.75 18.24 ± 0.56 
(Data are expressed in Mean ± SD) 
 
Table 40. 
Effect of Grewia tenax aqueous extract on MCHC level of iron-deficient rats (g/dl): 
 
Weeks 
Normal diet 
group 
Deficient diet group Grewia tenax group 
Week 0 31.98 ± 0.78 33.16 ± 0.76 32.54 ± 0.6 
Week 1 31.84 ± 0.52 33.02 ± 0.59 32.28 ± 1.2  
Week 2 32.02 ± 0.63 32.66 ± 0.54 31.74 ± 0.69  
Week 3 32.76 ± 0.18 33.42 ± 0.8 32.48 ± 0.5 
 
(Data are expressed in Mean ± SD) 
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Figure 24. Effect of G. tenax on Hb-level of hemorrhagic anemic rats 
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Figure 25. Effect of G. tenax on RBC count of hemorrhagic anemic rats 
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Figure 26. Effect of G. tenax on PCV level  of hemorrhagic anemic rats 
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Figure 27. Effect of G. tenax on Hb- level  of iron- deficient rats 
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Figure 28. Effect of G. tenax on PCV level  of iron- deficient rats 
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Figure 29. Effect of G. tenax on RBC count of iron- deficient rats 
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Figure 30. Effect of G. tenax on MCV level of iron- deficient rats 
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Figure 31. Effect of G. tenax on MCH level of iron- deficient rats 
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Figure 32. Effect of G. tenax on MCHC level of iron- deficient rats 
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3.3. Study of the effects of aqueous extracts of H. sabdariffa and A. 
garckeana on iron absorption: 
In this study, the control group has shown an increase in the iron concentration that 
was estimated by 130.31Mmol/L, 141.30 Mmol/L and 152.84 Mmol/L at incubation times of 
1, 5 and 15 minutes after the addition of FeSO4 solution.  
 20 mg/ml of H. sabdariffa extract has shown a decrease in the iron concentration 
measured as 127.25Mmol/L in the first minute and this decrease continued to the fifth 
minute then changed to an increase of 150.84 Mmol/L after 15 minutes past the addition of 
the FeSO4 solution. 
 In the third group, 20mg/mlof A. garckeana extract caused a decrease in the iron 
concentration estimated by 128.82 Mmol/L in the first minute of incubation time. However, 
the extract caused increases of 142.33 and 149.9 Mmol/L in the other five and fifteen 
minutes of incubation times, respectively as shown in table 41. and figure 33. 
 
Table 41. 
Effect of H. sabdariffa and A. garckeana extracts on iron concentration content by 
using everted gut sac method: 
 
 
Groups 
 
 
1 minute 
 
5 minute 
 
15 minute 
 
Control 
 
130.31 Mmol/L
 
141.30 Mmol/L
 
152.84 Mmol/L 
 
H. sabdariffa extract
 
127.25  
 
127.93 Mmol/L
 
150.84 Mmol/L 
 
A. garckeana extract
 
128.82 Mmol/L
 
142.33 Mmol/L
 
149.90 Mmol/L 
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Figure 33. Effect of H. sabdariffa and A. garckeana on iron absorption 
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4. DISCUSSION 
 
4.1. Effect of the tested extracts on hematological parameters of 
anemic rat 
 
4.1.1. The effect of H. sabdariffa aqueous extract on hemorrhagic 
anemic rats: 
 
The daily administration of 2 g/kg body weight of the aqueous extract of H. 
sabdariffa seeds has been continued for four weeks successfully. This extract has been found 
to cause clear changes in hematological parameters of the hemorrhagic anemic rats. This 
extract caused remarkable, yet not significant- increases in the hemoglobin, PCV and RBC 
levels of the anemic bled rats. The increases in the latter three parameters has started in the 
first week of the experiment and continued throughout the 4 weeks period. However, the 
increase in terms of the RBC count was slight and lower than that observed in the 
hemoglobin and PCV levels.  
These findings might possibly favour the traditional claim of using H. sabdariffa 
extract in the treatment of anemia. Also it was reported that, these findings coincide with 
previous studies conducted on the same plant; however, these findings were carried out on 
the aqueous extract of the calyces (Adigun et al, 2006).   
In the above mentioned study, 200 and 400 mg/kg of the aqueous extract of the 
calyces were administered to normal Wistar albino rats for 2 weeks. The extract has caused 
significant elevations in hemoglobin (P= 0.004) and PCV (P= 0.03) values. However, these 
beneficial effects of the extract were not sustained at higher doses (1000 mg/kg body 
weight). 
On the other hand, H. sabdariffa aqueous extract of the seeds was found to cause 
small increases in the MCV, MCH and MCHC levels of the hemorrhagic anemic rats. 
However, these increases were not recognizable and not significant.  
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4.1.2. The effect of H. sabdariffa aqueous extract on iron-deficient 
rats: 
 
Despite its effect on the hemorrhagic anemic rats H. sabdariffa extract of the seeds, 
did not cause the same effect on nutritionally iron-deficient animals. However, it has caused 
slight increase in the hemoglobin level in the first week of experiment that was not 
consistent because it was dropped in the second week. Also the extract was found to cause a 
slight increase in the MCV level accompanied by decreases in the MCH and MCHC levels.  
These results might confirm the beneficial effects of H. sabdariffa extract in 
counteracting the blood loss caused by the hemorrhagic anemia. However, it was found that 
it may not have the same positive action on the hematological parameters of nutritional 
anemia. This might be explained on the amount of iron content in the seeds of H. sabdariffa 
is not sufficient enough to counteract the deficiency in iron in the nutritional anemic animals.  
These effects of H. sabdariffa extract on hemorrhagic anemic and iron-deficient rats 
might be compared with previous study conducted on the anti-anemic effect of the aqueous 
extract of Sorghum bicolor (Oladiji et al, 2007).  
The study of the effect of aqueous extract of Sorghum bicolor was carried out on 21 
days old Wistar albino rats maintained on deficient and sufficient diets for 6 weeks before 
administration of the extract for a period of 7 days. It was found that the aqueous extract of 
Sorghum bicolor had produced significant increase in hemoglobin, PCV and RBC count in 
the iron sufficient and iron- deficient groups (P< 0.05). It was suggested that administration 
of Sorghum bicolor extract has restored the anemic condition in the iron deficient animals 
and thus lend credence to its use folklore medicine in the management of anemia. 
 
4.1.3. The effect of A. garckeana aqueous extract on hemorrhagic 
anemic rats: 
 A. garckeana is widely used by the natives in Western Sudan for nutritional 
purposes. This study has aimed to evaluate the efficiency of A. garckeana aqueous extract in 
treating anemia as has been assumed in the traditional use of this plant. Efforts were directed 
to assess any beneficial effects that may be shown after administration of the extract to 
anemic rats in two experimentally different models of anemia. In the first trial, the effect of 
2g/kg of A. garckeana aqueous extract was studied on the hematological parameters of 
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hemorrhagic anemic rats. This extract showed beneficial effects on some of the 
hematological parameters. It caused increments in the hemoglobin and PCV levels of anemic 
bled rats. These increments were found to be remarkable and convenient in the first and 
second weeks of treatment when compared to the increase in the hemoglobin and hematocrit 
levels of the control bled rats at the same period of time. However, in the third week all the 
three groups under study (treated and controls) attained normal and nearly equal values of 
hemoglobin and PCV levels.  
 This recovery time to the normal hematological values was shorter than fourth week's 
time that was reported in a previous study conducted on the aqueous extract of Ligaria 
cuneifolia (Dominighini et al, 2004). Another advantage caused by administration of A. 
garckeana extract is expressed in red blood cell count of the hemorrhagic anemic rats in the 
first and second weeks of treatment. This result favors the claimed hypothesis in the folk 
medicine that A. garckeana aqueous extract could have possible enhancing erythropoietic 
properties.  
 Observed changes in hemoglobin and PCV levels and RBC count were correlated 
with other blood indices e.g. MCV levels. 
 In the first week of the experiment, the control bled group showed elevated level of 
MCV which may be due to acute blood loss (macrocytosis i.e. macrocytic anemia). 
However, the extract was found to counteract the elevation in the MCV level and thus, the 
treated group showed lower levels of MCV comparabed to the control bled rats. 
 On the other hand, the extract did not show obvious alterations in the MCH and 
MCHC values throughout the study. Thus the MCHC values remained in the normal level 
which may be another evidence for macrocytic anemia.  
The effect of A. garckeana extract may be compared with another effect established 
in a study carried out formerly on Nigella orientalis plant (Kokdil et al, 2006). It was found 
that administration of 1 ml/kg/day of Nigella orientalis fixed oil to Wistar Kyoto rats for 28 
days, caused alterations in their hematological parameters. N. orientalis caused an increase 
in the MCV concentrations and a decrease in MCHC values when compared to the levels 
with of a control group that was administered with distilled water only during the study. On 
the other hand, Nigella segetalis was found to cause a significant increase in the hematocrit 
levels similar to the effect exerted by the A. garckeana extract.  
However, the effect produced by A. garckeana extract was found to be similar to 
those produced from daily administration of Khaya grandifoliola extract (Bumah, et al 
2005). The therapeutic efficacy of a crude water extract of Khaya grandifoliola has been 
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established in mice. This study was designed to assess the effect of the extract on the red 
blood cells and bone for 7 days, 3 weeks and a recovery period of 3 weeks. Daily 
administration of the extract showed a general pattern of significant (P < 0.5) increases in the 
red blood cell (RBC) count, PCV, hemoglobin and plasma iron content in the groups 
administered with the extract after 7 and 21 days when compared with control rats. 
 
4.1.4. The effect of A. garckeana aqueous extract on iron-deficient 
rats: 
When the effect of the aqueous extract of A. garckeana, was studied in nutritionally 
iron- deficient anemic rats, it was found that this extract did not cause any beneficial effects 
in terms of the hematology parameters( Hb levels and/or PCV levels). However, this extract 
was found to cause an increase in the red blood cell count of the anemic rats (3%) expressed 
in the third week of treatment. This increase was higher than that attained by the control rats 
that were fed with the normal iron- content diet. Thus, the A. garckeana extract caused 
increments in the red blood cell counts in both types of anemia, hemorrhagic and iron-
deficient anemias. Another observation is the increase in the MCV values that was caused by 
the extract in the second week of treatment.  
Results obtained after administration of A. garckeana extract to the iron- deficient 
rats revealed that this extract will have no advantageous effect in terms of MCH and/ or 
MCHC levels. It conversely caused lowering effects in those latter parameters when 
compared to the levels attained by the control group.  
On conclusion, A. garckeana extract was found to have stimulating erythropoietic 
properties when used in hemorrhagic anemia model. However, these stimulating effects were 
not found in iron- deficient anemia model, except of a minor increment showed in the red 
blood cell count of the treated group. Thus, further investigations should be conducted in this 
plant with other types of extracts and/or different doses so as to establish its stability in 
inducing favorable erythropoietic properties and its usefulness in the treatment of anemia as 
claimed in the folk medicine.  
 
 
 
95 
 
4.1.5. The effect of Grewia tenax aqueous extract on hemorrhagic 
anemic rats: 
Fruits of Grewia tenax are used widely in Sudan for purposes of treatment of anemia. 
A previous study conducted by Rahmatalla (1999) on the pulp juice extract of Grewia tenax, 
showed its beneficial effect on two groups of volunteers (doses of 100 gm and 150 gm 
respectively). Grewia tenax showed significant increases in terms of Hb and PCV levels of 
the second group after 3 weeks period of treatment. Also chemical analysis of Grewia tenax 
showed that it is a rich source of iron and vitamin C (average 9.1 mg Fe and 117 mg vitamin 
C/ 100 gm pulp). Hence, Grewia tenax is included in this study as a reference plant and to 
compare its effect in the correction of induced anemia with that produced by Azanza 
garckeana and Hibiscus sabdariffa aqueous extracts.  
 This study has elucidated that administration of Grewia tenax extract has caused 
favorable changes in many blood indices of hemorrhagic anemic rats. This extract has 
caused remarkable increases in the hemoglobin, PCV and red blood cell count levels of the 
anemic rats and also small increases in the MCV levels. But this effect was not detected in 
the MCH and MCHC values of the rats. Thus, these favorable effects of Grewia tenax in 
correction of hemorrhagic anemia supports a previous study carried out on the direct effect 
of G. tenax on iron absorption by using everted gut sacs of rats (Khemiss, 2006).  In this 
study, it was reported that the addition of aqueous extract of G. tenax at different 
concentrations to incubated freshly prepared rat everted gut sac has favored significantly iron 
transfer from the mucus side towards the serous one. The maximum of iron absorption has 
occurred in the presence of 10 mg/ml of the extract and 5 minutes of incubation time in 
stomach, duodenum and jejunum. 
Those findings may explain the positive effect of aqueous extract of G. tenax on 
blood indices of hemorrhagic anemic rats obtained in the present study.  
 
4.1.6. The effect of Grewia tenax aqueous extract on iron-deficient 
rats: 
 The effect of G. tenax on nutritionally iron-deficient rats was less 
recognizable than that in the hemorrhagic ones. The extract has caused small increases in the 
Hb and PCV levels of iron-deficient rats that appeared in the first and third weeks of 
treatment. On the other hand, the effect of G. tenax extract on the red blood cell counts has 
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been detected as an increase in their levels when compared to the levels of the control 
untreated animals.  
Conversely, the extract did not show any favorable increasing effects on the MCV, 
MCH or MCHC levels of the iron deficient rats. Instead, there were small decreases 
appeared in the parameters of those animals.  
Thus, this study revealed that the aqueous extract of G. tenax could correct the blood 
indices in cases of acute blood loss as found in hemorrhagic anemia and this might be due to 
its effect on iron absorption in the gut but these effects are not shown in cases of nutritional 
anemia when there is no enough iron to make all the red blood cells the body needs.   
 
4.2. Study of the effects of aqueous extracts of H. sabdariffa and A. 
garckeana on iron absorption: 
It is well known that, maximum iron uptake is normally detected in the duodenum 
and maximum of iron uptake occurs at 15 minutes of incubation time. Thus, in this study the 
duodenum was the tissue that was chosen for studying the effects of H. sabdariffa and A. 
garckeana extracts on direct iron absorption. These effects are also compared to that of G. 
tenax extract. In a former study, it was found that G. tenax extract caused maximum iron 
uptake at 5 minutes of incubation time and registered at the duodenum at a dose of 10 
mg/ml. However, Grewia tenax extract used at a dose of 20mg/ml has favored iron transfer. 
An increase in the absorption was detected at 5 minutes and 15 minutes of incubation times. 
This decrease was not significant at 1 minute of the incubation time.  
 In the current study, 20 mg/ml of H. sabdariffa and 20 mg/ml of A. garckeana 
extracts caused decreases in the iron concentration at the first and fifth minutes of incubation 
for the H. sabdariffa extract and at the first minute only for the A. garckeana extract. 
However, these decreases were not proven statistically.  
 Comparison made between the three extracts revealed that the G. tenax extract has 
had the best capability of iron transfer among the three extracts after 5 minutes of incubation 
time. Followed by the extract of H. sabdariffa with less capability of iron absorption at the 
same incubation time. The least is the A. garckeana extract which showed less iron uptake at 
the first incubation minute and that effect was transient disappeared at the fifth minute of 
incubation.   
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5. CONCLUSION 
  
This study aimed to investigate and explore the efficiency of three medicinal plants 
extracts on hematological parameters of two different types of anemia. Also it aimed to 
confirm the claim for the use of these extracts in the folk medicine for the treatment and 
correction of anemia.   
From all these studies conducted, it is found that the three plants extracts of G. tenax, 
A. garckeana and H. sabdariffa have had the capabilities to increase hematological 
parameters in induced hemorrhagic anemia. However, the extract of A. garckeana  has 
showed this capability in the first and second weeks of treatment only i.e. transient effect. 
The three extracts showed the tendency to increase the haemoglobin levels and red 
blood cell counts of the bled animals (except for last weeks in case of A. garckeana extract). 
Studies conducted on iron-deficient anemia, showed that G. tenax and H. sabdariffa 
caused small and equal effects on the increases in the  Hb-levels of the iron-deficient animals 
in the first week of treatment only and the effect was combined with equal small effect on 
the red blood cell counts in the first and third weeks of treatment.  
The above findings were confirmed by the fact that G. tenax extract has had the 
highest amount of iron. Whereas H. sabdariffa had the less amount of iron than did the A. 
garckeana extract but it seemed that iron contained in the former plant was more available. 
Another confirmation for this study is the findings of the everted gut sac studies. A. 
garckeana being the least extract in capability of iron transfer compared to capability of H. 
sabdariffa and / or G. tenax extracts. 
These results may support positively the use of these three plants extracts in folk 
medicine for the correction of anemia. 
 
Recommendations: 
 
• This study investigated one dose of each plant, so it is recommended that higher 
doses must be studied to evaluate the whole effect of these plants. 
• Types of extracts other than the aqueous one can be investigated. 
• Detailed pharmacological and toxicological studies must be carried out before these 
plants can be introduced as anti-anemic agents.   
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